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INTRODUCTION: 
 
Cancer is the second leading cause of death in the USA with about 575,000 deaths each 
year and a disease for which death rates are increasing. Between 2000 and 2050, the 
elderly population in the USA is projected to increase by 135%[1]. Moreover, the 
population aged 85 and over, which is the group most likely to need health and long-term 
care services, including cancer care services is projected to increase by 350%. 
Approximately 60% of cancer patients are treated with external beam radiotherapy at 
some point during management of their disease. The goal of radiation therapy (RT) is to 
maximize the dose to the target while limiting the dose to nearby healthy organs or organ 
at risk, (OAR), in order to improve tumor control and normal tissue toxicity. 
Radiation therapy is primarily used to treat cancer by locally targeting radiation 
to the gross tumor volume (GTV) with added clinical target volume that accounts for 
microscopic extensions of the disease (CTV) and an additional planning target volume 
(PTV) that accounts for setup and localization errors . The concept of GTV, CTV and 
PTV to report dose prescription is discussed in the review paper [2]. Radiation beams are 
produced by medical linear accelerators which have now imaging capabilities including 
volumetric imaging using cone beam CT integrated into the treatment delivery process. 
The linear accelerators are mounted on a gantry with a rotating couch, gantry and 
collimator to allow for many beam directions to be focused on the target volume.  
Avoidance of normal tissues is accomplished by directing multiple beams at the target 
using a beams eye view (BEV) of the target, thus delivering a high dose where the beams 
intersect at the target, and a relatively lower dose outside of the intersection and also by 
  2 
modulating the intensity of radiation using Multi Leaf Collimator (MLC) so that the 
maximum dose is delivered to target. Biological sparing of normal tissue is accomplished 
by fractionating the radiation therapy over several weeks with tumor typically being 
irradiated 5 days in a week. The tumor tissue lacks repair mechanisms to repair DNA 
damage from the radiation, whereas normal tissues can repair minor DNA damage. 
Therefore, by fractionating the treatment, normal tissues are provided time to repair, thus 
biologically sparing the normal tissue. 
Although conventionally fractionated radiotherapy is delivered in a four to eight week 
time period,  radiation therapy treatment planning is carried out based on information that 
is currently limited to a single 3D anatomical computed tomography (CT) image data set 
acquired at the onset of treatment design (Fig. 1a). The patient is typically marked for 
repeated alignment with localization lasers in the treatment room. The treatment planning 
is then performed on the CT scan where beam geometries, energies, and collimation are 
determined either by inverse planning using intensity modulation or using conventional 
3D conformal therapy techniques, and the resultant dose distribution is computed. This 
concept may result in significant treatment uncertainties, including geometric miss of 
target/tumor and resulting in excess irradiation of organs at risk (OAR). An example to 
highlight this is shown below in Fig 1 in the case of head and neck cancer patient. 
Fig 1 a, refers to the planning CT used for treatment planning, fig 1b refers to the CT 
acquired on first day of treatment showing correspondence to the planning CT. Fig 1c is 
the CT acquired on the last day of treatment and illustrates how the patient’s aquaplast 
mask does not fit to the external skin due to the weight loss or other changes. A plan 
  3 
delivered based on planning CT to this CT geometry may result in unacceptable OAR 
and tumor doses. 
 
Figs 1.1 a, b, c illustrating the patient’s CT anatomy during planning CT, first day of 
treatment and last day of treatment respectively 
1.2 Imaging workflow in radiation oncology: 
Imaging is included in the radiation oncology process in a variety of ways.  The approach 
taken depends upon: the type of imaging, the availability of the on board imaging 
technology on the linear accelerator (kilo voltage x-ray imaging, cone beam CT, CT on 
rails, MVCT etc...) the clinical objective, and, and the presence of other imaging 
modalities for multi-modality imaging and registration.  The most commonly used 
imaging modalities of CT, PET and MRI and its workflow process in radiation oncology 
is discussed in this section. 
1.2.1 CT Imaging in Radiotherapy Workflow 
CT images are utilized for pre-treatment imaging; treatment planning and treatment 
verification for radiation treatments can be outlined as in Figure 1 below. It should be 
noted in the current setting; ART involves the patient being rescanned for a new 
treatment planning CT in the flow of images from linac to CT as shown in fig 1. 
a b c 
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Figure 1.2.  Workflow for CT-based radiotherapy. (Adapted from reference 3) 
  5 
With the availability of multi-modal imaging for diagnosis and therapy response, the 
imaging work flow in a modern radiation oncology department [3] can be represented as 
shown in Fig 1.3 below. 
 
Figure 1.3: Progression of the radiation therapy workflow towards an image guided  
radiation therapy process, in which images from a variety of imaging modalities are used 
in the design of the therapy.  These images are registered using both rigid and non-rigid 
methods and used for visualization and manual or automated segmentation. Imaging in 
the room is now being more broadly employed to both evaluate geometric targeting (e.g., 
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cone-beam CT, MVCT, etc..) and adaptation based on delivered dose (Adaptive radiation 
therapy)( Adapted from reference 3) 
 A treatment plan is developed based on contouring target volume quantified by patient 
specific imaging i.e. CT, MRI or PET. Appropriate margin expansion for CTV to PTV 
margins for tumor/target can be defined based on quantifying the systematic (Σ) and 
random (σ ) errors as defined by Van herk’s formulae[4] 
 Δ(CTV-PTV Expansion)  = 2.5 Σ + 0.7 σ 
Once a treatment plan has been approved, the plan, isocenter and DRRs or CT scan itself 
are sent to the linear accelerator.  DRRs are used for comparison with megavoltage or 
kilovoltage planar images for appropriate patient alignment.  The CT scan is used to 
estimate appropriate patient alignment by registration and fusion of the CT scan with 
volumetric images acquired at the linear accelerator which can be kilovoltage or 
megavoltage, cone beam or fan beam.  CT imaging is the most dominant imaging used in 
the entire workflow of radiation oncology process.  
1.2.2 Positron Emission Tomography (PET) imaging for target Definition and 
therapy response in Radiation Therapy 
Positron emission tomography (PET) provides functional information on tumor, and may 
also identify the extent and location of active disease. This technique is based on the 
injection of a radioactive tracer with short half-life. The half-life of radioactive 
 
F
18
 to 
trace glucose metabolism using the fluorodeoxyglucose, (FDG) is two hours. The tracer 
concentrates on the area of interest with increased metabolic activity and whose activity 
can be detected using gamma ray detectors. PET/CT scans can be acquired separately 
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and can be integrated with treatment planning using rigid and non-rigid registration 
techniques or may be performed as part of radiation therapy simulation to adjust target 
volumes. PET imaging can also be used to assess tumor response or recurrence after 
completion of radiation. An example of PET imaging pre and post radiation therapy is 
shown below in figure 1.4 as discussed in reference[5]. SUV or Standardized Uptake 
Value is a convenient measure for monitoring and assessing therapy response and is 
calculated either pixel-wise yielding a parametric image, or over a region of interest 
(ROI). This may be done for any image acquired at time point t, or for all images of a 
dynamic series acquired at multiple time points. The SUV is commonly defined as the 
ratio of the tissue radioactivity concentration c (e.g. in MBq/kg = kBq/g) at time point t, 
and the injected activity (e.g. in MBq, extrapolated to the same time t) divided by the 
body weight (e.g. in kg): 
SUV (t) = 
    
                     
            
 
  8 
 
Figure 1.4: PET imaging showing tumor response before and after completion of 
radiation therapy (see reference 5 for details) 
1.2.3 Magnetic Resonance Imaging (MRI) use in Therapy Planning and Response 
MRI image data can be used in the radiation therapy treatment planning process in 
several ways. Currently morphological data from MR based on T1, T2 imaging and 
similarly weighted images, together with contrast agents can be used to define tumor and 
organ extent as shown in fig 1.5 for a brain tumor example. 
Figure 1.5. T1 and T 2 images of MRI of brain 
T1 
T2 
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There is growing use of functional and metabolic information to complement 
morphological images. These data used can either by digitally transferred to a planning 
system and co-registered with CT, with and without prior distortion correction. 
Alternately the data can be used directly for planning after distortion correction and with 
bulk assignment of attenuation corrections (MR simulation).  
MR simulation requires appropriate set up of the patient in the treatment position, 
registration of surface markers, and assurance of spatial accuracy. Registration to CT also 
benefits from these steps.  MR may also be used to assess changes in target volume 
during therapy and to assess response and residual disease following treatment.   
1.3 Clinical rationale for Adaptive Radiation Therapy: 
1.3.1 Introduction to ART 
The term adaptive radiation therapy was originally coined by Di Yan [6] . Adaptive 
radiotherapy has been introduced as a feedback control strategy to include patient-
specific treatment variation explicitly in the control of treatment planning and 
delivering radiation during the treatment course[7]. The goal of adaptive radiation 
therapy is not only to address inter and intra fraction changes but also to take 
advantage of treatment variation in the individualized treatment optimization. The 
potential of adaptive radiotherapy extends beyond the increase of radiation dose 
delivery accuracy. It could also improve radiotherapy efficacy after patient-specific 
biological changes are incorporated in the adaptive optimal control process. Most 
clinical applications of adaptive radiotherapy have been limited to target position 
correction alone (IGRT), and the extensive feedback information obtained during 
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the treatment course has not been fully used in treatment optimization. In the 
following section we present an overview of various approaches to ART and its 
clinical rationale. 
1.3.1 On-line and Off-line Analysis for In-room Image Guidance 
Once the technical development and optimization of in-room imaging tools integrated 
with the actual treatment process, the next important step is the development and 
implementation of clinical protocols for image-based guidance[8]. There is a variety of  
information available in the literature describing such protocols for adaptive radiation 
therapy for different anatomical sites and a nice summary can be found in Seminars in 
Radiation Oncology[9].  It is well known from daily imaging arising from Image Guided 
Radiation Therapy (IGRT) that dose delivery to tumor and organs at risk is affected by 
inter-fraction and intra-fraction motion of organs. Intra-fraction motion defined as motion 
when the radiation beam is delivered occurs due to variety of physiological changes in 
anatomy like breathing, cardiac motion, rectal peristalsis and bladder filling etc. Inter-
fractional (day-to-day) geometric change occurs over the weeks of radiation therapy, due 
to digestive processes, change of breathing patterns, difference in patient setup, and 
treatment response like growth or shrinkage of the tumor or nearby organs at risk. In the 
past, these changes were taken into account by population-based “uncertainty” margins 
around the target area, which may be excessive or conservative and are broadly applied to 
the structures identified before the therapy begins. 
Daily imaging from IGRT has provided clinicians and physicists tools to quantify patient 
specific anatomical changes and thereby devise strategies to incorporate these changes in 
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plan optimization. This approach has the promise to improve therapeutic ratio by 
simultaneously incorporating both dose escalation to the tumor and reduction of dose 
given to organs at risk. This has already resulted in dose escalation strategies using larger 
fractions size hypo-fractionated regimen (Prostate, Lung etc.) by increasing the chance of 
local control without increasing toxicity. 
Adaptive radiotherapy (ART) is currently mostly based on an off-line approach where the 
anatomical and biological changes are monitored over the course of treatment, and the 
treatment is modified when significant changes are identified. However with increased 
automation, on-line ART (while the patient is still on treatment table) can be achieved in 
principle. On-line ART has been implemented by select research groups and its potential 
benefit has been demonstrated for bladder, prostate and head & neck disease sites.[10-12] 
IGRT is typically an on-line concept where the patient or treatment plan is shifted or 
modified for each treatment.  
Off-line analysis has also been used to quantify and separate random and systematic 
uncertainties for individual patients. This information can be used to design decision 
rules to indicate when to correct a set-up deviation for a particular type of treatment, see 
reference [13] for details using electronic portal imaging devices(EPID). Off-line set-up 
verification protocols using EPID can be based on decision rules using a shrinking action 
level (SAL) as discussed in reference [14]. Other approaches are based on average 
deviations observed during the first number of fractions and assuming these deviations 
are valid for the whole treatment, e.g. the no-action level (NAL) protocol [15].  
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However the most significant impact for ART necessity has resulted from the volumetric 
CT (CBCT, MVCT, etc.) acquired at the time of daily treatment. This has resulted in 
variety of adaptive therapy options that will be discussed next. 
By using image information obtained during the first week of treatment, the PTV margin 
can be adapted for an individual patient. A new plan can then be designed using the 
average GTV and OAR positions. In the following weeks, new scans are used to monitor 
the adequacy of the ART treatment plan. It should be noted that the clinically applied 
GTV-to-PTV margins should compensate for all geometrical uncertainties in the 
radiotherapy chain including those induced by target definition, which are not improved 
by in-room image guidance. However 3D image guidance can point to the need for plan 
adaptation based on soft tissue imaging. An example for a head and neck patient is given 
below based on CT scans acquired 3 weeks apart. As seen in Figs 1.6 a, and b, there is a 
significant decrease in tumor volume on the CT scan taken 3 weeks after start of therapy. 
If the original plan had been delivered to the new patient geometry this would have 
resulted in a severe overdose of parotid as seen in figure 1.6 d. The parotid in this 
example would have received 70Gy instead of the 45Gy originally planned, resulting in 
unacceptable toxicity for the patient. Thus a robust strategy to implement ART is 
required to improve therapeutic ratio. 
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Figure 1.6 a, Tumor volume at the treatment planning CT scan, b, Tumor volume, 3 
weeks after start of treatment showing shrinkage of tumor, c) Isodose distribution on 
original CT , d) isodose distribution on new anatomy if original plan was delivered 
without adaptation 
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1.4 Motivation, goals and scientific contribution of this dissertation 
This dissertation aims to develop the necessary scientific knowledge to include organ 
deformation in adaptive dose delivery. Our goal in this dissertation is to develop 
methods and tools based on scientific insight gained to account organ deformation in 
the adaptive dose feedback loop that would ultimately help physicians and physicists 
in the radiation oncology community to better serve their clinical needs. In that 
context, several scientific concepts have been proposed and validated and will be 
highlighted in this section. 
 It is widely accepted that ART accounting organ deformation is a clinical requisite 
and would be greatly beneficial to a certain group of patients receiving radiation 
therapy for different anatomical sites[9]. In this dissertation we first demonstrate the 
need for ART in the treatment of localized prostate cancer and propose plan 
adaptation without deformable image registration tools[16]. However 
implementation of ART is a daunting task as quantifying and accounting anatomical 
changes manually (without deformable image registration) is extremely time 
consuming and not practical in a clinical environment[16]. Deformable image 
registration (DIR) has the potential to map anatomical changes in imaging data 
between two study sets which exhibit organ deformation. Clearly the challenge in 
DIR is to account these anatomical changes accurately to ultimately implement 
cumulative dose tracking on a reference study set. 
DIR based voxel mapping being inherently degenerate, (as in there is no unique 
solution) is a particularly challenging yet extremely important problem in validation 
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for radiation oncology applications. DIR accuracy in the context of radiation therapy 
can be separated into two parts a) validation of image registration from various 
algorithms, b) validation of deformable dose registration (dose warping). Scientific 
methods for both features are proposed and limitations of existing methods are 
examined in this dissertation.  
This dissertation aims to develop tools to independently perform deformable image 
registration (DIR) using open source platform[17] ( 3D Slicer) and propose a frame 
work to validate the accuracy of DIR with an emphasis on radiation oncology 
applications[18]. A novel method of verifying DIR accuracy using virtually 
simulated deformation to mimic clinically observed organ deformation was proposed 
and validated. Independent validation tools for verifying accuracy of image 
registration are implemented using open source modules[18]. The second step in 
implementing ART involves calculating the doses to a deforming anatomy. Again, 
re-planning and re-optimization of treatment plans as done for treatment planning CT 
cannot be applied to daily imaging data because of the time and resource constraints. 
Dose warping defined as applying the deformation vector field (DVF) arising from DIR 
on the original dose distribution has the potential to account for organ deformation and 
accumulate doses. However its application and validity in a clinical environment remains 
controversial[19] .  
The vast majority of research work that has been done on dose warping accuracy studies 
has only examined arbitrary deformations of varying magnitude for dose delivery 
verification. This dissertation proposes to examine the fundamental science of 
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deformation linked to its causative physical force. A quantitative relationship between 
force and deformation may give insight into the deformation characteristics of various 
organs if the biomechanical properties of tissues like Young’s modulus and Poisson ratio 
are known. This can be potentially used to create simulated deformations of various 
organs analogous to what has been done for surgical simulations. A database of simulated 
deformations for various organs in response to applied force can give clinicians insight 
into how an organ may deform over an entire course of radiation therapy and can be 
potentially be used to adapt margins in a dose painting /dose escalation scenario. 
  There is a large growing database in the surgical community that has quantified the 
biomechanical properties of organs. A force-deformation relationship has important 
applications in surgical simulations, optimizing surgical tool design,  creating "smart" 
instruments capable of assessing pathology or force-limiting novice surgeons, and 
understanding tissue injury mechanisms and damage thresholds [20].  
In general soft tissue organ deformation can be thought of as a bio-feedback between 
physics and anatomy & physiology of organs. A medical simulator including soft tissue 
organ deformation can be thought of in a three generation step model as shown in figure 
1.7 and discussed in[21-25].  The first generation of medical simulators only considers 
the geometric nature of human organs like variations in shape, volume etc... This can be 
easily quantified using the wide variety of modern imaging methods available. The 
second generation of medical simulators aims to model the physical interaction of human 
organs. Clearly for radiation oncology applications, understanding soft tissue deformation 
and a potential simulation of organ deformation is of paramount importance. This 
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dissertation aims to study the physical interaction of organ deformation (second 
generation medical simulator) by quantifying the deformation with its causative physical 
force which in a clinical scenario may be linked to the influence of neighboring organs. 
The third generation of medical simulators accounts for the functional nature of organs 
and are more complicated in design and scope. The flow chart (Figure 1.7) shows how 
different levels of simulation (anatomy, physics and physiology) interact with one 
another. In a radiation therapy context, occurrence of tumor in an organ (physiological 
process) will modify the biomechanical properties of the tissue (physics). For example it 
is known that the mean density of parotid glands (physics) varies during the course of 
head and neck IMRT therapy due to changes in tumor size (physiology) and salivary flow 
(physiology)[26, 27]  
To achieve such advanced simulations, it is necessary to model the phenomena occurring 
at the geometric, physical and physiological levels. Although rapid progress has been 
made in deformable image registration (DIR), more research effort is needed in physical 
modeling of organ deformation from a physics perspective. In particular, modeling soft 
tissue organ deformation is likely to be a key ingredient in creating second and third 
generation medical simulators from the context of radiation therapy applications. 
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Figure 1.7  Three different generations of medical simulators illustrating the interplay 
between physics, physiology & geometry of the organs. (Adapted from reference 25) 
To explore the relationship between deformation and its causative physical force a 
deformable bladder phantom with mechanical and tensile properties comparable to an 
adult human bladder was designed and built using a tissue equivalent viscoelastic 
polymer substance. Using this fundamental relationship, the accuracy of dose 
deformation arising from commercial DIR algorithms was investigated.  A threshold limit 
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for dose warping was ascertained and established from various commercially available 
DIR algorithms beyond which dose recalculation is the deformed geometry is necessary. 
The applicability of dose warping to dose painting scenarios was investigated. This 
dissertation also highlights the need to validate the volume of dose from dose warping as 
traditionally used 3D gamma pass rates used by most research studies may not accurately 
describe dose warping for dose painting.  
1.5 Organization of this document 
This document is organized as follows.  
Chapter 2 details the clinical need for adopting ART in the treatment of localized prostate 
cancer. Specifically imaging data from 10 patients was analyzed using both kvCBCT 
from Elekta Synergy and MVCT from Tomotherapy system. The feasibility of direct 
dose calculation on kvCBCT and MVCT images as well as quantitative soft tissue 
contrast comparison between the various imaging modalities is discussed. ART options in 
the absence of DIR using the planned adaptive software on the Tomotherapy system are 
outlined.  Our results clearly demonstrate the need to develop a strategy that includes 
deformable image registration to adopt ART.  
Chapter 3 details the technical principles and physics of DIR and the various approaches 
of DIR transformation functions with a focus on radiation oncology applications.  Details 
of similarity measures, deformation models and optimization methods for various 
algorithmic implementations are discussed. 
Chapter 4 gives a framework in validating the accuracy of DIR algorithms. The lack of 
verification scheme is one of the major drawbacks in adoption of DIR into clinical 
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practice. We propose a novel method by synthetically deforming CT data with a known 
applied deformation and using the deformation vector field (DVF) arising from that to 
evaluate the accuracy of DIR. Various methods and relative strengths of these methods in 
evaluating the accuracy of DIR is presented in Chapter 4. As discussed before, dose 
tracking based on dose warping is the next logical step towards implementing ART. 
However the accuracy and application of dose warping in a clinical environment remains 
controversial as warping the dose with DVF may not represent the physical process of 
dose deposition from radiation transport principles in a deformed anatomy.  
In Chapter 5 we describe a novel deformable bladder phantom made of a viscoelastic 
polymer substance developed in this project towards verifying the accuracy of dose 
warping. “Deformable dose” from commercial DIR algorithms was compared against the 
“true” dose received by organ in deformed state to illustrate at what deformation, dose 
recalculation in deformed anatomy may be clinically necessary. Dose warping was first 
evaluated using 1D point dose measurement with implanted MOSFETS in the deformed 
anatomy. Five parallel air canals running through the phantom were used to position 
the MOSFETS in deformed anatomy. The dose directly measured by MOSFETS in 
deformed anatomy was compared to the warped dose from 2 DIR algorithms. 
However 1D point dose measurement for an arbitrary deformation cannot be 
considered a comprehensive validation of verifying dose in a deforming anatomy. 
For this reason we modified our phantom to parameterize deformation with applied 
physical force. The importance and scope of quantitative relationship between force 
and deformation is highlighted in Chapter 5. Both 1D deformation along the axis of 
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applied force and 3D deformation of organ were quantified. Using the fundamental 
relationship established between force and deformation we assess 3D dose 
comparison for dose warping. Details of verification scheme and applicability 
methods to dose painting are discussed in Chapter 5. 
Chapter 6 gives general summary and conclusions of the dissertation and highlights 
the application of current work to other clinical applications in lung cancer and TMI. 
A model for on-line adaptive radiotherapy is discussed for future clinical 
implementation. 
Appendix details the diffeomorphic demons and B-spline algorithms implemented as 
part of this dissertation, as plug-in modules using 3Dslicer as the visualization 
platform. A detailed procedure manual to perform DIR and evaluate the accuracy of 
DIR is presented. 
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Chapter 2: Implementation and framework of adaptive radiation therapy for 
prostate cancer. 
2.1 INTRODUCTION 
This chapter details the clinical rationale and methodology used in implementing 
adaptive radiotherapy for prostate cancer. The framework suggested as part of this 
dissertation were published in peer reviewed journal, Journal of Applied Clinical Medical 
Physics, Ref [16] and is discussed in this chapter. 
The goal of a radiation treatment as discussed before is to ensure that the target receives 
accurate and adequate dose coverage while the dose to the critical structures is kept as 
low as possible. Intensity Modulated Radiation Therapy (IMRT) [33-35]  and IGRT have 
led to more precise conformal radiation therapy. Conformal therapy has the potential to 
enhance the therapeutic ratio (dose to tumor/Organ at Risk (OAR)). However, due to the 
complexity of treatment delivery and variation in patient/tumor intra-fraction and inter-
fraction position, treatment may still pose risks for a geographic miss [36, 37]. 
The use of CT Imaging in IGRT technology to localize the prostate, bladder and rectum 
each day has made it possible to deliver the dose to the target more precisely. It is well 
known that the confirmation of the relative position and shape of the target and organs at 
risk during daily fractionated treatment is of fundamental importance to accurate dose 
delivery [38]. Although the primary aim of IGRT technologies in the treatment of 
prostate cancer is to accurately localize the tumor for precise targeting, these technologies 
are also capable of monitoring changes in the filling and shape of the bladder and rectum. 
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The ability to monitor and quantify the daily changes in these critical structures is 
necessary to track the actual dose delivered to them.  
The current study evaluates 10 patients for the dosimetric changes due to inter-fraction 
organ motion associated with the treatment of prostate cancer. The two IGRT 
technologies used in the study include Megavoltage CT (MVCT) localization on the 
Tomotherapy Hi-ART machine and kilovoltage Cone Beam CT (kvCBCT) localization 
using the Elekta Synergy system. A framework that can be applied to adapt plans for 
patients treated on the Tomotherapy Hi-ART system was created. The framework 
includes a method to analyze the cumulative Dose Volume Histogram (DVH) calculated 
by the Planned Adaptive Software. These evaluations can then be incorporated into a plan 
modification with the aim of minimizing the differences between planned and delivered 
doses.   
Although previous studies [39] with the Tomotherapy system have demonstrated daily 
dose recalculations, to the best of our knowledge, our study is the first one to attempt to 
create a summation dose and evaluate the dosimetric impact of taking into account the 
changes in daily parameters. The dosimetric information can be used to modify a patient 
plan or Planning Target Volume (PTV) margins based on the evaluation of actual dose 
received. 
2.2 Methods and Materials 
2.2.1 kvCBCT dose calculation accuracy on Elekta Synergy 
The actual dose delivered to the prostate, bladder and rectum for 5 patients was 
investigated by using the daily anatomy information provided by kvCBCT images. The 
feasibility of direct dose recomputation on the kvCBCT images was investigated using 
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the ComTom CT Phantom. The ComTom phantom consists of 37 pins, each 1’’ in 
diameter, which are arranged in 3 concentric rings. There are 18 pins in the outer ring, 
each spaced 20 degrees apart. There are 9 pins in the middle and inner rings respectively, 
all spaced 40 degrees apart. The CT numbers of the 9 pins plus air encompass the range 
of x-ray attenuation normally found for human tissue. The relative electron density of the 
materials in this phantom (compared to a value of 1.0 for water) varied from 1.87 in 
Teflon to 0.15 for low density polyurethane. The kvCT scan of the phantom is shown in 
Figure 2.1.  
5 patients were randomly chosen for this study. Our standard IMRT treatment for 
definitive prostate cancer includes seven equally spaced beams using 10 MV photons in a 
step and shoot delivery. All patients were treated to a dose of 75.6 Gy in 42 fractions. The 
treatments were planned and optimized using the CMS XiO treatment planning system 
and the dose calculation was performed using a convolution/superposition algorithm. The 
PTV margin routinely used at our institution for prostate IMRT is 1 cm in the 
superior/inferior direction, 8 mm everywhere else except posteriorly where the margin is 
5 mm. The patients were instructed to have a “full bladder” at the time of CT simulation 
and during daily treatment. The current study did not include any analysis of seminal 
vesicles coverage. 
One full volumetric kvCBCT study set was randomly chosen for every patient from each 
week of treatment. A total of 9 CT study sets (Week 1 to Week 9) were used for each 
patient to analyze the prostate, bladder and rectal volume changes and their impact on 
dosimetry. The kvCBCT scans were manually contoured by the same Radiation 
Oncologist to account for any deformation in the target, rectum and bladder. The 
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kvCBCT scans were fused with the treatment planning CT scans and the dose was 
recomputed on the treatment planning CT scan.  A two-step process was used in 
registering the kvCT (primary study set) with the kvCBCT (secondary study set) 
scans/images. The primary and secondary study sets were transferred to the CMS Focal 
workstation. An automatic registration was performed to automate the alignment between 
the two study sets. The software computes the geometric transformation that best 
registers corresponding anatomic details in the two study sets of the same patient’s 
anatomy. The alignment criterion is mutual information (MI) which is a measure of the 
statistical similarity of the overlapping data. The transformation that gives the maximum 
value of MI is considered to be the best registration. In the second step, interactive 
registration was used to further refine the automatic registration performed by the 
software. The radiation oncologist manually inspected and refined the alignment of the 
prostate between the kvCBCT and kvCT study sets based on soft tissue match.  
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Figure 2.1 kvCT image of the ComTom Phantom.  
2.2.2  Soft tissue contrast comparison of kvCT, kvCBCT, and MVCT scans 
The Catphan 600 phantom (Phantom Laboratory, Salem, NY) was used in order to 
quantitatively evaluate and compare the soft tissue contrast between the three imaging 
modalities (kvCT, kvCBCT and MVCT). Additionally, the low contrast resolution, image 
uniformity and spatial resolution were compared. The kvCT, kvCBCT and MVCT 
images of CTP 404 module of Catphan 600 phantom are given below in Figures 2.2a–c. 
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Figure 2.2a. kvCT image of the CTP 404 module of Catphan Phantom. 
 
  
Figure 2.2b. kvCBCT image of the CTP 404 module of Catphan Phantom. 
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Figure 2.2c. MVCT image of the CTP 404 module of Catphan Phantom. 
Low Contrast Resolution is the ability of the imaging system to distinguish between 
relatively large objects which differ only slightly in density from uniform 
background[40] . 
The 3D Low contrast resolution (LCR) is computed from the mean and standard 
deviation of the pixel values of polystyrene and LDPE found in the CTP 404 module of 
the Catphan phantom using the formula [41] 
LCR = 
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)(75.2
LDPEPoly
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Image artifacts due to equipment design, beam hardening or image reconstruction 
software can manifest themselves as systematic CT number variations. Hence, scanning a 
uniform phantom and sampling CT numbers in the fixed areas can quantify the presence 
of systematic variations. The 3D uniformity is computed from the pixel values of three 
locations in the CTP 486 uniformity module of the Catphan 600 phantom using the 
formula [41] 
3D Uniformity =   
100
)(
)()(


highMean
lowMeanhighMean
 
Spatial resolution characterizes the imaging system’s ability to distinguish between two 
very small objects placed closely together. Spatial resolution measurements are 
performed with objects which have high contrast from uniform background. Spatial 
resolution is frequently referred to as high contrast resolution [42]. The 3D high contrast 
or spatial resolution of the three imaging modalities was calculated by imaging and 
measuring the resolution pattern on the line pair phantom (CTP 528 module) which has a 
range of spatial frequencies.  
2.2.3 Adaptive Tomotherapy 
The details of MVCT image reconstruction during Tomotherapy are well known and 
have been discussed by Ruchala et al. [43]. The energy of the MVCT beam (3.5 MV) is 
lower than that of the treatment beam (6 MV). The accuracy of dose calculation on the 
MVCT images was reported by Langen et al and has also been independently verified at 
our institution [44]. 
The MVCT images are limited to a 40 cm circle of reconstruction due to the limitation of 
the maximum Tomotherapy collimator width, whereas, the kvCT studies usually have a 
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50 cm circle of reconstruction or larger in case of big bore CT scanners. MVCT scans are 
also typically shorter in the patient’s cranio-caudal direction to save time and reduce the 
imaging dose. Planned Adaptive software inserts the 40 cm field of view MVCT images 
into the corresponding kvCT treatment planning study by creating a combined 
MVCT/kvCT image study set. This is referred to as the merged image. Typically kvCT 
images are acquired with a slice thickness of 3mm and MVCT scanning on Tomotherapy 
has three possible slice thicknesses: fine ( 2mm), normal ( 4mm) and coarse ( 6mm). 
Therefore, interpolation within the MVCT image set is required to maintain a uniform 
3mm slice thickness. A different image-value-density table (IVDT) is used for 
performing dose calculations with MVCT images due to the higher beam energy of the 
Tomotherapy unit (3.5 MV) as compared to the kvCT images. It has already been shown 
that the dose calculation is accurate using the merged images on the Planned Adaptive 
Software when compared to the same plan using the kvCT image [45]. 
In the Planned Adaptive software the original contours used for treatment planning on the 
kvCT study set are overlaid on the merged images, and they are re-contoured, if 
necessary, based on anatomy of the day. Using the merged images as the imaging dataset 
for adaptive plans assumes that the regions of interest outside the MVCT scan in patient 
anatomy have not significantly changed because the MVCT images cover only limited 
length in the cranio-caudal direction. Planned Adaptive software calculates verification 
doses for each patient. This is done by applying the daily delivery sinogram (based on the 
original kvCT plan) in the calculation of dose distribution on the merged image.  
Through the Planned Adaptive software, a summation dose, which is the addition of 
verification doses from each treatment fraction, was generated and compared against the 
  33 
planned dose. Once the summation doses have been created, a cumulative DVH is 
constructed in the Planned Adaptive Software.  Planned Adaptive software facilitates the 
modification of structures (based on patterns of accumulated dose that may have resulted 
in over or under dosage) in the merged image set.  The resultant modified structures are 
then transferred to the Tomotherapy Planning Station for optimization of an “adaptive” 
plan. Adaptive planning allows adjustment of the remaining treatments to correct for 
changes that have occurred up to that point in treatment. Depending upon the anatomical 
site and clinical scenario, additional verifications and adaptive plans can be generated to 
correct for further anatomy variations. This paradigm is called Adaptive Tomotherapy 
Planning.  
5 prostate patients were randomly chosen for this part of this study. All patients were 
treated in supine position using the Helical Tomotherapy unit at University of Minnesota. 
The patients were implanted with three gold seed markers to help align the MVCT study 
set with the kvCT study set and also to minimize inter-user variability in registering 
images. 
The positional variations of inter-fraction organ motion for each treatment fraction were 
systematically monitored and characterized using onboard MVCT images. The 
registration values used to position the patient at the time of treatment were used to 
correct the MVCT scan when creating the merged scan. The rectum and bladder were re-
contoured manually on merged study sets incorporating the bladder and rectal daily 
variation as determined on the MVCT scan. There were only minimal changes in the 
prostate target volume definition on the MVCT scans as compared to kvCT scan. The 
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merged images created with the MVCT scans were then used to create adaptive treatment 
plans using Tomotherapy Planning Station. 
The reconstructed doses were compared with calculated treatment planning doses for 
individual organs through cumulative dose volume histograms (DVHs). The purpose of 
the comparison was to determine if treatment plan improvements can be dosimetrically 
significant and to distinguish between clinically significant and insignificant anatomy 
changes. Cumulative DVHs from the planned adaptive software were analyzed for each 
patient and adaptive radiotherapy strategies were formed based on our analysis of these 5 
patients. 
2.3. RESULTS 
2.3.1. CT number vs. electron density using kvCBCT scans with Elekta Synergy 
The CT number derived from the kvCBCT image was found to vary considerably 
(average variation of 283 HU) from the kvCT image as seen in Figure 2. The CT 
numbers derived from the kvCBCT scans showed the largest deviation from the 
corresponding values from the kvCT image for low relative electron density materials 
such as polyurethane with a maximum deviation of 684 HU for the low density 
polyurethane. Further, the CT number reproducibility for the same material 1 cm superior 
and inferior to a given central axis slice varied by as much as ± 200HU compared to the 
value on the central axis slice. Hence, it was concluded that direct dose re-computation 
on Elekta kvCBCT scans is not accurate or feasible at this time. 
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Figure 2.3 Relative Electron density vs. CT number variation for kvCBCT and kvCT 
scans of ComTom Phantom. 
2.3.2 Prostate, bladder and rectal volume and dose changes using kvCBCT scans on 
Elekta Synergy 
Before each treatment, a kvCBCT scan was acquired and the prostate was aligned to the 
kvCT. The same physician was present and performed the alignment of kvCBCT with 
kvCT to eliminate inter-user variability and interpretation of soft tissue images. The 
CBCT scan for the prostate was imaged at 120 kVp and 1040 mAs. Based on our 
measurements on the CIRS body phantom, this is equivalent to an imaging dose of 2.8 
cGy at the center per day, for a total of 118 cGy over 42 fractions. This dose was not 
added to the actual treatment dose in dose comparisons. 
Figure 4 shows the rectal volume changes in the 5 patients analyzed from each week 
based on the kvCBCT scans contoured by the same Radiation Oncologist. Week 0 
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represents the rectal volume from the treatment planning kvCT scan. As seen in Figure 4 
below, there is a large variation in the rectal volume over the 9 week period. 
Radiation Therapy Oncology Group (RTOG) 0126 criteria of volume of rectum 
receiving 75 Gy (V 75 Gy) was chosen to track rectal doses from kvCBCT scans. This 
is equivalent to the percentage of rectal volume receiving the daily fraction dose of 
180 cGy as compared to the rectal volume from the treatment planning kvCT scan. 
This is illustrated in Fig. 5. Due to the changes in rectal filling on the day of treatment, 
the maximum variation in rectal volume receiving the percentage of prescribed dose 
was as high as 12% (patient 3, Week 3). 
 
 
Figure 2.4 Changes in rectal volume over the course of treatment (42 fractions). 
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 Figure2.5 Change in percentage of rectal volume receiving 1.8 Gy relative to the 
treatment plan value listed by patient. Positive values indicate an increase in the volume 
of the rectum receiving 1.8 Gy; negative values indicate a decrease in rectal volume at 
that dose. Each column represents data from one selected daily cone-beam scan per 
consecutive week of treatment. The average over these values for the course of treatment 
is shown by the yellow bars. 
Figure 6 shows the bladder volume changes for the 5 patients treated 
using the Elekta Synergy system. There was a large variation in bladder 
volume, especially for patient 2, when compared against bladder volumes from 
the kvCT. In this study sample, the bladder volumes seem to decrease during 
treatment when compared to kvCT volumes. Radiation Therapy Oncology Group 
(RTOG) 0126 criteria of volume of bladder receiving 70 Gy (V 70 Gy) was 
chosen to track bladder doses from kvCBCT scans. This is equivalent to the 
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percentage of bladder volume receiving the daily fraction dose of 170 cGy as 
compared to the bladder volume from kvCT scan. The results are reported in 
Fig. 7. Due to the changes in bladder filling on the day of treatment, the 
maximum variation in bladder volume receiving the percentage of prescribed 
dose was as high as 40% (patient 5, Week 3). 
Finally, the changes in prostate target dose, based on recomputation of dose 
using the changes in the target volume as outlined in the kvCBCT images, were 
evaluated. The target dose change compared to planning dose is minimal as 
would be expected from positioning with daily image guidance. This is outlined 
in Fig. 8. 
 
 
Figure 2.6 Change in bladder volume over the course of treatment (42 fractions) for all 5 
patients. 
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Figure. 2.7 Change in percentage of bladder volume receiving 1.7 Gy relative to the 
treatment plan value listed by patient.  Positive values indicate an increase in the volume 
of bladder receiving 1.7 Gy, while negative values indicate a decrease in bladder volume 
at that dose.  Each column represents data from one selected daily cone beam scan per 
consecutive week of treatment.  The average for these values over the course of treatment 
is shown in yellow. 
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Figure 2.8 Change in mean target dose relative to the plan value for each patient.  Each 
column represents data from one selected daily cone beam scan per consecutive week of 
treatment.  The average for these values over the course of treatment is shown in yellow 
2.3.3. Soft tissue contrast comparison of kvCT, kvCBCT, and MVCT scans 
As expected, the kvCT images provided the best contrast resolution while the MVCT 
displayed the poorest. The quantitative values for the 3 imaging modalities are listed in 
Table 2.1 given below. 
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Imaging Modality 
3D Low contrast 
Visibility 
3D IMAGE 
UNIFORMITY (%) 
3-D SPATIAL 
RESOLUTION (line pairs) 
MVCT 3.19 9.3 4 
kvCBCT 1.73 0.9 7 
kvCT 0.11 0.044 7 
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Table 2.1. Quantitative comparison of contrast resolution in the 3 imaging modalities of 
MVCT, kvCBCT, and kvCT. 
2.3.4 . Dose tracking using MVCT on Tomotherapy HI-ART system 
Of the 5 patients analyzed using an Adaptive Tomotherapy plan, 3 showed minimal 
differences between planned and delivered dose in terms of cumulative DVH. Instead of 
reporting cumulative doses received by each organ, the data was analyzed in terms of 
cumulative DVH as reported by the Planned Adaptive software. Three different scenarios 
out of the 5 patient cases analyzed were picked to discuss adaptive radiotherapy 
strategies. A 10 % difference between planned and delivered mean dose was used as the 
threshold for target and critical structures in deciding whether or not to re-optimize a 
given plan.  
Scenario I - good agreement between Planned and Delivered dose (Less than 5 % 
difference between planned and delivered mean doses) 
 Figure 9 displays a scenario where there is good agreement between planned and 
delivered doses after manually contouring on 42 study sets to account for volume 
changes in the bladder, rectum and target. The delivered summation dose for the target is 
slightly more than the planned dose. Overall, based on the Adaptive Tomotherapy plan, 
the actual delivered dose to the patient is in close agreement with the planned dose. In 
such a scenario, a new treatment plan with the merged study set is not required. 
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Figure 2.9 Good Agreement between planned and delivered doses using Planned 
Adaptive software; Dashed line: summation dose. Solid line: planned dose. Cyan line: 
bladder. Brown line: Rectum. Red line: Prostate. 
Scenario II - minimal differences between planned and delivered dose (less than 10% 
difference between planned and delivered mean doses) 
For this patient, the cumulative DVH derived from the summation of verification doses is 
given below in Figure 10. As shown in Figure 10, the cumulative rectal DVH (dashed 
line) is less than the planned DVH for the rectum. The cumulative target DVH is less 
than the planned DVH for the target with the target receiving slight under-dosage even 
though the prescription dose is still covered by the 95% isodose line. Even though the 
planned doses and delivered doses differ slightly (less than 10% threshold limit), a plan 
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modification using the merged study set would not be considered necessary in this 
scenario. 
 
  Figure2.10 Minimal differences between planned and delivered doses using Planned 
Adaptive software; Dashed line: cumulative DVH. Solid line: planned DVH. Cyan line: 
bladder. Brown line: Rectum. Red line: Prostate. 
Scenario III: delivered dose NOT in agreement with planned dose (Greater than 10% 
difference between planned and delivered mean doses) 
Figure 11 shows a patient for whom a Tomotherapy boost of 28.8 Gy over 16 fractions 
had been prescribed to be delivered to the prostate. In this particular patient there was a 
large variation in dose delivered to the rectum when compared with the planned dose. 
The large variation was a result of the patient having a distended rectum during planning 
which caused the volume of rectum irradiated during actual treatment delivery to be 
smaller in most fractions. A 10% difference between planned and delivered mean doses 
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was used as our threshold limit in deciding whether or not to re-optimize the plan based 
on the actual dose delivered. For this particular patient, after reviewing the cumulative 
DVH, the patient plan was modified off-line by choosing a different optimization scheme 
to account for the volume changes in the rectum from daily MVCT scans. 
 
Figure 2.11 Large Differences between planned and delivered doses using Planned 
Adaptive software; Dashed line: cumulative DVH. Solid line: planned DVH. Pink line: 
bladder. Brown line: Rectum. Red line: Prostate. 
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The resulting adapted plan is given below in Figure 12, displaying that the planned and 
delivered doses to target, bladder and rectum are now in close agreement.
 
 
Figure 2.12 Re-optimized plan from the adaptive information whereby planned and 
delivered doses are now in agreement. 
2.4 DISCUSSION 
Positional variation of prostate gland in the treatment of prostate cancer has been 
extensively studied and various Image Guided Technologies which can potentially 
correct for these variations have also been reported. [46-59]. 
Several studies recently in the literature [60-62] [63-65]
  
have shown that dose escalation 
is necessary and leads to an improved clinical outcome in the treatment of prostate 
cancer. Dose escalation, however, leads to increased dose to the critical structures, 
namely bladder and rectum, even with the IMRT treatment modality. There have also 
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been studies which have demonstrated the efficacy of hypofractionated treatments for 
prostate cancer [66-68]given the low 
α
/β[69-72]  value suggested for prostate cancer.  In 
this scenario, the precision and accuracy of the dose delivered to the target and critical 
structures takes on a greater significance. The evaluation of actual dose delivered to the 
prostate, bladder and rectum based on the anatomy of the day may become a clinical 
necessity for these treatments. 
Our study involving kvCBCT with Elekta Synergy system clearly demonstrates that in 
the absence of any special protocol that involves bowel preparation, daily soft tissue 
imaging with the kvCBCT scans show large variations in delivered dose to bladder and 
rectum with the confirmation that the dose delivered to the prostate is satisfactory. Thus 
while clearly IGRT with daily soft tissue imaging improves the accuracy of dose 
delivered to prostate it also has the potential to document and monitor changes in 
anatomy and dose to the critical structures (i.e. bladder and rectum) 
The changes in bladder and rectal volume were random in nature and the clinical impact 
of such variations cannot be well understood unless we quantify the changes and sum the 
doses from one CT scan to the other using a deformable registration model which were 
not done in this study.  The variations of bladder and rectal volumes from weekly 
kvCBCT scans are displayed on the treatment planning CT scan in Figure 13. Currently 
there are no commercial treatment planning systems that have the ability to carry out such 
an analysis in an automated manner. Consequently, even in this study which takes into 
account only a weekly kvCBCT scan for each patient, the time required to do a 
dosimetric analysis of this nature is not practical in a busy clinical setting. Working with 
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the Radiation Oncologist, the physicists in this study spent approximately 3 hours per 
patient to contour bladder and rectum on each 3D kvCBCT studyset.   
 Various strategies have been suggested for off-line adaptive radiotherapy using kvCBCT 
scans in the literature [8, 73-77]. Most involve the creation of a modified target and 
rectum based on the evaluation of daily kvCBCT scans from the first few fractions and a 
modified treatment plan created for the rest of the treatment course based on these 
structures. 
We have shown that the maximum variation in rectum and bladder volumes in our 
kvCBCT study receiving the percentage of prescribed dose was 12% and 40% 
respectively. These large variations could be clinically significant. Clearly the challenge 
is to create cumulative DVH information to interpret the volume changes occurring 
during IGRT.  
This was our motivation to perform the study with the Tomotherapy system using the 
Planned Adaptive software tool. As stated before, 5 patient plans were evaluated with this 
adaptive planning method to determine whether treatment plan improvements could be 
dosimetrically significant and to distinguish between clinically significant and clinically 
insignificant anatomy changes. 
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Figure 2.13 kvCT superimposed with kvCBCT contours showing variation in bladder and 
rectal volumes for a patient over 9 week period.  
The cumulative DVH information from the merged MVCT-kvCT images also gives us 
re-planning options should a significant discrepancy exist between planned dose and 
delivered dose. Our analysis of 5 patients treated on the Tomotherapy Hi-ART system 
found that there was a significant improvement in the treatment plan for one patient based 
on the cumulative DVH analysis from planned adaptive software and subsequent 
reoptimization of the plan.   
Deformation of organs is a complicated process if organ wall changes are to be 
quantified. The deformation of the organ wall was not included in our analysis for 
bladder and rectum using the MVCT images. The bladder and rectum were assumed to be 
  49 
“filled” organs while re-contouring on the MVCT and kvCBCT study sets. The soft tissue 
contrast was found to be insufficient for organ wall delineation. A sample MVCT image 
with and without the original kvCT contours are given below in Figures 14a and 14b to 
illustrate this point. 
 
 Figure 2.14(a) MVCT scan of patient illustrating lack of sufficient image contrast for 
rectal wall delineation. 
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Figure 2.14 b. Outline of MVCT indicating rectum but the rectal wall cannot be 
visualized. 
2.5 Adaptive Re-planning 
 The re-planning options can be divided into the two broad strategies of off-line and on-
line options.  The off-line approach is the most practically feasible approach to 
implement today and a practical implementation strategy is provided here. The off-line 
approach requires cumulating all of the actual delivered doses by accounting for the daily 
volume changes of prostate, bladder and rectum. Therefore in principle, an adaptive 
treatment plan can be created at the end of each week to evaluate for any potential 
changes in delivered dose as compared to planned dose delivery using the cumulative 
DVH.  If a significant discrepancy occurs (greater than the 10% mean dose difference 
threshold) as shown in scenario 3, a re-optimization of the plan will be done to account 
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for these changes. A final plan will then be created which results in a DVH that closely 
matches or has a superior dose distribution when compared to the original planned 
distribution based on the feedback from the changed anatomy. 
In cases where there are only minimal differences in the cumulative DVH midway 
through the treatment, the original plan will continue to be used for patient treatment and 
a final adaptive summation plan will be created at the end of patient treatment with the 
cumulative DVH demonstrating the planned and actual dose delivered. The Adaptive 
Tomotherapy plans for these cases will serve as a clinical quality assurance tool to 
document that the actual delivered doses were in agreement with the planned dose. The 
main drawback of performing the planned adaptive plans is that they are extremely time 
consuming because all the contours have to be manually drawn as in our kvCBCT study. 
An average of 12 hours per patient was spent to contour an entire 42 fraction MVCT 
study set. The other major drawback is that although the summation dose is computed in 
the planned adaptive software this only evaluates the summation dose for one MVCT at a 
time and does not include a deformable registration model which can potentially follow 
the doses delivered to the voxels creating an overall dose pattern. We are currently 
actively pursuing deformable registration tools with MVCT to create such models. 
The on-line adaptive therapy process accounts for the deformation of the prostate, 
bladder and rectum using deformable registration tools based on the anatomy whereby 
DVH is created and compared to the planned DVH while the patient is on the table. Thus 
any changes to the plan or positioning of the patient is done not just by image registration 
data but after on-line evaluation of dose. This process can only be implemented if there 
are automatic software tools which evaluate the deformation of the prostate, bladder and 
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rectum in real time and feed the information to the optimization engine such that DVH 
can be generated in real time while the patient is still on table.  
2.6 CONCLUSION 
Our study involving both kvCBCT and MVCT image guidance have shown the ability to 
track actual doses delivered to prostate, bladder and rectum based on anatomy of the day. 
Due to the large variation in CT number on the kvCBCT images with the Elekta Synergy 
system we conclude that direct dose computation on these images is not feasible. We 
have also quantitatively evaluated the low contrast resolution, spatial resolution and 
image uniformity of the 3 imaging modalities of kvCT, kvCBCT and MVCT using 
CatPhan 600 phantom and have found as expected that the kvCT and kvCBCT images 
have better contrast resolution than the MVCT images. 
Using the planned adaptive software on the Tomotherapy system, our study has 
demonstrated the ability to sum doses from multiple fractions on the merged kvCT-
MVCT study set in order to construct and evaluate a cumulative DVH. We have 
demonstrated a clinical process where using the adapted plan, an adjustment to treatment 
plan optimization may be performed whereby actual delivered doses are in agreement 
with the planned dose based on the information gained from daily MVCT scans. To take 
this investigation further, one has to develop deformable registration tools which can be 
used to calculate cumulative doses to organs at risk and target volumes thereby providing 
a valuable tool for evaluating adapted plans. It is our belief that such evaluations will 
eventually pave the way for a dose-guided radiotherapy paradigm in the treatment of 
localized prostate cancer.  
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Chapter 3 Overview of Deformable Image Registration (DIR) 
3.1 Introduction: 
The problem of registering medical images has been the subject of active research for 
many decades. The fundamental science of image registration is determining a spatial 
transformation – or mapping – that relates positions in one image, to corresponding 
positions in one or more, other images. The meaning of correspondence varies and takes 
different significance depending on the application. For example, the user may be 
interested in structural correspondence [78] (e.g. lining up the same anatomical structures 
before and after radiation treatment to detect response), functional correspondence (e.g. 
lining up functionally equivalent regions of the brains of a group of subjects) or 
structural–functional correspondence (e.g. correctly positioning functional information on 
a structural image). These have resulted in a variety of different registration algorithms 
which are continuously evolving based on the application of image registration to a 
particular area of interest.  
From a radiation oncology perspective, there are three broad applications of medical 
image registration and deformable image registration (DIR) in particular. These are 1) 
Identifying and correlating tumor or organ of interest across a series of medical scans 
(e.g. CT, CBCT, or MRI). 2) Matching of images from different patients (inter-patient 
registration) which has applications in atlas based segmentation, 3) Multi-modal 
registration which means matching images of the same patient acquired by different 
imaging modalities.( CT to MRI or CT to PET/CT etc…) 
However the basic ingredients on how a DIR algorithm is operational is the same [78] 
and is reviewed in this chapter. Any DIR algorithm has three basic components i) 
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similarity measures of how well the images match, ii) deformation model ( parametric or 
non-parametric models) which specifies how a source or moving image can be made to 
match target or fixed image, iii) optimization process that varies the parameters of a 
particular deformation model to maximize the matching criterion. 
Deformable registration is inherently degenerate and is considered an ill-posed problem 
because there is generally no unique solution to a registration problem. Usually image 
registration is presented as an optimization problem. Registration methods can be based 
on information derived from image intensities or from landmark information (such as 
contours or points) placed on the images. Hybrid models are possible using a 
combination of intensities and landmarks.  A review of DIR and the algorithm 
implementation details from the perspective of radiation oncology applications will be 
presented here. First we review two classical definitions of DIR as an image matching 
problem borrowed from theoretical imaging science. 
3.1.1. DIR definition 
 Based on reference [79]deformable image registration can be defined as finding the 
functions h and g in the following mapping between two 3D images I1 and I2: 
I2(x, y, z) = g (I1 (h(x, y, z))) 
where I1 is called the source or moving image and I2 is called the reference or target 
image. The images I1 and I2 can be thought of as mappings from 3D coordinates to image 
intensities. 
The function g is called an intensity mapping function that accounts for a difference in 
image intensities of the same object in I1 and I2. In other words it is used to describe so-
called 1D intensity differences.  The function h is used to describe geometric differences. 
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It is a spatial 3D transformation that describes the mapping between the spatial 
coordinates (x, y, z) in the reference image to map the coordinates (x’, y’, z’) in the 
source or moving image 
so that (x’, y’, z’) = h(x, y, z). These transformations take different forms depending 
on the registration method used. 
2. Alternately way to define DIR matching is presented in the recently published review 
paper in IEEE [80] and is described below based on that review paper.  Let us consider 
source (moving) image as S and fixed or target image as T. The two images are defined 
in image domain Ω and are related by a transformation W. The goal of registration is to 
estimate the optimal transformation that optimizes energy of the form  
M (T, S ο W) + R(W).  
The objective function defined above comprises two terms. The first term M, quantifies 
the level of alignment between a target image T and a source image S . This term is 
commonly refereed as similarity criterion in DIR. 
The optimization problem consists of either maximizing or minimizing the objective 
function depending on how the matching term is chosen. The images get aligned under 
the influence of transformation W. The transformation is a mapping function of the 
domain Ω to itself, which maps point locations to other locations. In general, the 
transformation is assumed to map homologous locations from the target physiology to the 
source physiology. The transformation at every position, x є Ω, is given as the addition of 
an identity transformation with the displacement field, u , or W(x) = x + u(x) 
The second term R, regularizes the transformation ( for example smoothing with 
Gaussian etc..) aiming to favor any specific properties in the solution that the user 
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requires, and seeks to tackle the difficulty associated with the problem. Regularization 
and deformation models are closely related. 
In the case that the transformation is parameterized by a small number of variables and is 
inherently smooth, regularization may serve to introduce prior knowledge regarding the 
solution that we seek by imposing task-specific constraints on the transformation. 
Second, in the case that we seek the displacement of every image element (i.e., 
nonparametric deformation model), regularization dictates the nature of the 
transformation. Before we describe deformation models commonly used in radiation 
oncology applications, a review of similarity measures is presented 
3.2 Similarity measures 
The quality of how well the images are matched after deformable image registration is 
defined by the similarity measures. The two input images into DIR in reality are never 
perfectly matched. Instead a similarity measure is defined, and the optimal registration is 
the one that features a transformation which minimizes this measure. The commonly used 
similarity measures are discussed below based on Ref [50])  
3.2.1 Sum of squared differences (SSD) 
The most widely used similarity metric is the sum of squared differences (SSD) measure 
defined as: SSD = 1/N Σx {T(x)-S(t(x))}
2
 
Where T(x) is the intensity at a position x in an image and S(t(x)) is the intensity at the 
corresponding point given by the current estimate of the transformation t(x). N is the 
number of voxels in the region of overlap. 
SSD is very sensitive to voxels with large intensity differences (outliers) which makes 
SSD only applicable in single-modality registration (e.g. both must be CT or MRI images 
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etc..) contexts, or more precisely, in cases where the images to be registered only differ 
by noise when registered. The least-squares form of SSD makes the measure 
computationally very attractive since fast optimization schemes can be used. 
3.2.2 Correlation Coefficient (CC) 
The Correlation Coefficient metric can be written as: 
CC =   
             
                 
 
          
              
 
As this is a quadratic form, the same highly efficient numerical methods can be applied as 
for the optimization of SSD-based measures. Usually CC is not suited for multi-modality 
registration since a global linear transformation function of the grey values cannot be 
presumed. However, in a number of small neighborhoods the assumption of a linear 
relationship is valid and the correlation coefficient can be used as an indicator of image 
similarity. This metric has the advantage that it has a reduced dependence on linear 
scaling of image intensities. This means that two images can be registered even though 
one is brighter than the other. 
3.2.3 Mutual Information: 
As discussed in review papers [78-80] [81] image registration can also be considered 
within an information theoretic framework. The basic idea is to exploit a statistically 
significant relationship between the grey values of the input images. This relationship 
does not have to be explicitly known but rather only assumes a probabilistic relationship 
between intensities. The only fact used is that proper registration means proper alignment 
of significant grey value structures that through their statistical relationship lead to 
pronounced peaks in the joint grey value distribution detected as maxima of its mutual 
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information or entropy. The mutual information can be defined in terms of entropies of 
the intensity distribution 
MI = HT + Hs-HT,S 
and HT = - Σi Pi, log Pi ,  Hs = - Σj Qj log Qj and Hi,j = - Σi,j pi,j log pi,j 
where P and Q are probability of intensity i and j occurring in target and source image 
respectively and pi,j is the joint probability of both occurring at the same time. 
MI has evolved into the accepted standard for similarity measures especially in multi- 
modality imaging. 
3.2.4 Normalize Mutual information (NMI) 
This is defined as NMI = (HT + HS)/ HT,S 
This metric was proposed to minimize the overlap problems occasionally seen when 
using the MI metric. 
3.3 Deformation Models: 
Deformable image registration models can be divided into those using parametric 
based registration (model based) and those using non-parametric ones. The parametric 
methods are characterized by featuring a transformation function that is described by a 
limited number of parameters. The parametric methods are also classified as geometric 
transformations derived from interpolation theory[80]. These typically include a) Radial 
basis functions (RBS), b) Elastic body splines (EBS) and Thin plate splines (TPS), c) free 
form deformation using B-splines etc. Using basis functions with compact support, a 
change of a parameter only affects the transformation in a spatially limited neighborhood 
while other parts of the deformation remain unchanged. Hence, with respect to image 
resampling, only the relevant part of the image has to be resampled, which improves the 
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computational performance of DIR. 
In contrast to this, non-parametric methods typically feature a transformation function 
that is based on a vector per voxel describing the displacement of the point represented 
by this voxel. This is converted to a continuous function by interpolation. The non-
parametric deformation models are also called as geometric transformations derived from 
physical models by some authors. These include d) elastic body models that obey Hookes 
law etc. e) Viscous fluid flow methods that obey Navier stokes equation etc.., f) Diffusion 
models like demons registration  g) optical flow methods like Horn and Schunck 
algorithm etc. 
3.3.1 Parametric or model based deformation models: 
A registration method based on a parametric transformation function is usually written as 
a minimization problem in which an optimal set of parameters must explicitly be found 
that minimizes the chosen similarity measure. Typically parametric based deformation 
models rely on constructing a mapping function which maps points from moving (source) 
image to the corresponding landmark points in fixed (target) image. 
The matching of point features in source and target (reference) images can also be done 
manually by a trained anatomy expert based on fiducial markers placed before image 
acquisition or image features extracted from images after scanning.  
3.3.2 Transformations based on radial basis functions 
A generalized way to describe the geometric transformation is creating a 
global function based on a set of radial basis functions (RBF), which are functions 
depending only on the distance between two points. Thin plate splines (TPS) are an 
example of radial basis functions that are derived from minimization of a smoothness 
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measure based on the partial derivatives of the transformation[82] . A known 
synthetically induced deformation using TPS model is used to verify the accuracy of DIR 
in this dissertation and is discussed in the next chapter. The name “thin plate” refers to a 
physical analogy of bending a thin sheet of metal plate orthogonal to the plate such that 
the plate will arrange itself in a configuration where the bending is evenly distributed or 
producing radially symmetric transformations. 
A number of other basis functions for RBF-based transformations have been 
proposed for image registration including elastic body splines (EBS), Wendland 
functions[83]  and Gaussian functions. 
3.3.3 Adaptation of Insight Segmentation Tool Kit (ITK) Thin Plate Spline: 
 ITK uses a variation of the elastic body spline [84] to implement the thin plate spline. 
The elastic body spline is obtained by solving the Navier equilibrium partial differential 
equation for a homogeneous isotropic elastic body subjected to loads [84]:  
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. µ and λ are the coefficients that describe the physical 
properties of the materials derived from Young’s modulus (E) and poisson ratio, (υ) and 
can be written as 
E = 
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. The solution to equation (1) given the force field 
is: 
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The passion ratio  ]2/[   and   1112   . I is the identity matrix. The form 
of )(xG

for the ITK TPS implementation is as follows: 
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The matrix block element )(xG

in the ITK TPS implementation is a 3x3 matrix. The 
“traditional” thin plate spline [82] )(xG

is replaced by 1x1 matrix  As noted [84], this 
difference derives from the assumption that individual displacements in each coordinate 
axis in the “traditional” thin plate spline is independent. The ITK implementation of the 
thin plate spline assumes that the displacements in each ordinate are coupled as a direct 
consequence of being parts of the solution solving the equation (1). The stiffness of the 
splines could be adjusted by the stiffness factor . When   is set to zero, one obtains the 
interpolating splines [85]. 
Other ITK kernel splines  
The TPS is a member of a family of splines available in ITK for deformable alignment. 
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Other spline models available are given below. 
–Thin Plate Reciprocal Spline: G(x) = r(x)
2
log(r(x))×I.      (5) 
–Elastic Body Spline (EBS): G(x) = ((12×(1−ν)−1)r(x)
2 
×I−3xx T )×r(x) where ν is the 
Poisson’s ratio.                                                                   (6) 
–Elastic Body Reciprocal Spline: G(x)=((8×(1−ν)−1)r(x)×I−3x x T /r(x)).   (7) 
–Volume Spline: G(x) = r(x)
3 
× I.                                        (8) 
The variants are based on variants plugged into the solution of G(x), see reference [84] 
for details. 
3.3.4 Transformations based on a grid of control points 
B-splines: 
B-splines are a commonly used deformation model in radiation oncology applications 
and have been used in commercial implementation of DIR software as well (Velocity 
AI). A common approach to parameterizing a transformation using basis functions is 
to base the transformation on a number of control points arranged in a regular 
grid and four basis functions .In short, a function is represented as a linear combination of 
basis functions such that 
             
 
 
where    is a scaling function and β(u) is a piecewise cubic polynomial and, 
β o(u) = (1 − u)
3
/6 
β 1(u) = (3u
3
 − 6u2 + 4)/6 
β 2(u) = (−3u
3
 + 3u
2
 + 3u + 1)/6 
β 3(u) = u
3
/6 . 
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The four piecewise polynomials are shown in the figure 3.1 below. 
 
Figure 3.1 Graphical representation of four piecewise polynomials in B-spline algorithm 
Using these it is possible to develop a transformation function which is locally 
controlled , i.e when a control point is moved the points in the vicinity are transformed 
This technique is sometimes called free form deformation (FFD). The compact support of 
the BSplines means that when evaluating the effect of moving a control point, only the 
vicinity of this point needs to be considered. In  a cubic B-spline FFD transformation 
approach is applied in registration used in mammography for breast cancer [86]. This 
registration is based on MR images and using MI as similarity measure for creation of 
external forces.  
The B-spline approach combined with Mattes MI similarity metric has been widely used 
for several applications in  radiotherapy[87-89] 
3.3.5 Mesh based models 
Mesh based models perform DIR ( also known as deformable mesh registration (DMR) 
based on dividing the entire image into polygons (2D) or polyhedra (3D), where the 
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subdivision follows boundaries in the images. This can be used for finite element analysis 
based methods in image registration.[90, 91] 
A number of authors have based their registration approach on using organ 
segmentations for creating a mesh of points connected by triangles (organ surface), and 
tetrahedra or hexahedra (entire organ volume). Recently this method was used to verify 
the accuracy of automatic target registration by comparing tumor and lymph nodes 
delineated by an anatomy expert on weekly CT scans with those derived from mesh 
registration[92]. 
3.4 Non-parametric deformation models 
Non-parametric deformation models or transformations are typically described by 
a field consisting of a displacement vector per voxel of the reference image. A continuous 
transformation function is defined by interpolation between these vectors and 
consequently the DVF generated in non-parametric models constitute a vast number of 
degrees of freedom. The non-parametric deformation models are also sometimes called 
free form deformation in some of the published work. 
3.4.1 Methods for non-parametric registration 
Deformation models in parametric approaches to some extent are regularized 
by the continuous nature the parametric functions. However regularization is crucial 
when using non-parametric transformations. In this section some examples will 
be given of non-parametric registration methods which rely on physical properties based 
on an underlying physics to guide the registration process. 
3.4.2 Linear Elastic matching 
Hooke’s law of elasticity describes the strain, the deformation a body undergoes, 
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when subjected to a stress, the force per unit area. Under Hooke’s law this is a 
linear relationship is described by 
F = −kx, 
where x is the change in length of the object, F is the restoring force exerted by the 
body, and k is the spring or force constant. Hooke’s law can be rewritten, in terms 
of stress and strain, as 
σ = E* ε, where E is  young’s modulus and σ and ε are the applied stress and strain . The 
deformation along the axis of applied force follows Hooke’s law and can be written as 
x =  
  
 
 = 
 
 
 
 
 
  where E= Young’s modulus of organ and 
 
 
(force per unit area) is the 
applied load. 
In a simple 2 D model the deformation in a direction perpendicular to the direction of 
applied force ( Δ H) can be written in terms of the Poisson ratio of a particular organ as 
follows: y = 
  
 
 =  
 
 
 * 
 
 
 where υ is the poisson ratio of the individual organ defined as the 
ratio of transverse contraction strain to longitudinal extension strain that describes the 
compressibility of a material. Typical organ Young modulus and poisson ratio are given 
in Table 3.1below that can be used in biomechanical algorithms based DIR[91]. 
Organ Poisson’s ratio (υ) Young’s modulus (E) 
(kPa) 
Lung 0.45 5.0 
Bladder 0.45 16 
Breast 0.45 19 
Liver 0.45 7.8 
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Spleen 0.499 50 
Kidney 0.499 24 
Stomach 0.499 500 
Interior 0.4 1.5(abdomen) to 6.0(thorax) 
Table 3.1 Typical Young Modulus and poisson ratio of organs used in DIR 
biomechanical algorithms 
3.4.3 Demons Algorithm 
The demons registration method was introduced by Thirion[93] and has been used in 
several radiotherapy applications.[94-96] 
Optical flow is used to find a driving force at each point based on the intensity gradient of 
the image. The allowed transformations are described using a vector field where each 
voxel has an associated deformation vector describing where this voxel is mapped to in 
the reference image. The main concept here is to drive the voxels of the moving image in 
the direction of the gradient  f if their intensity is higher than the corresponding intensity 
of voxels in fixed image and in the opposite direction if intensity is lower. To regularize 
the flow a Gaussian filter is used.  
The Demons algorithm defines the deformation fields as 
)(xu

 
  -     
          
 = 
       
       
 
where (m-s) is the external force or the differential force between static and moving 
images and     is the gradient of the static image. 
This method  has been validated on a wide variety of radiotherapy applications[94, 95].  
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3.4.4 Viscous-fluid registration 
A registration method designed to handle large geometric displacements between 
two images is the viscous-fluid registration method by Christensen [97]. The general idea 
in this method is to use a motion model that is derived from continuum physics that 
describes the motion of a viscous fluid for regularizing the registration process. 
The general equation can be described using Navier-Stokes equation namely 
)()]([)()(2 xfxuxu

     
For an incompressible fluid, the conservation of energy, momentum, and mass lead 
to the Navier-Stokes equations to describe the motion of a fluid substance. In the 
viscous fluid model equation above, μ is set to 1 and λ to 0, resulting in the simplified 
equation 
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 The driving force in the viscous-fluid registration is a body force vector field that is 
derived on the basis of image intensities finding the local direction of steepest 
decrease of an SSD similarity measure. The method is very time consuming because it 
requires an iterative solution of a partial differential equation (PDE) and in each iteration 
another PDE must be solved to find a vector field of velocities.  
An example of viscous-fluid registration method extended to include the use of 
landmark information was used in cervical cancer registration with patients with CT 
compatible intra cavitary applicators[98]. A hybrid model is presented here in which 
regions of interest are converted to binary volumes. These volumes are included when 
body forces are calculated which makes it easier to assure that structures of importance in 
the images are matched.  
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3.4.5 Optical flow based registration methods 
The process of estimating optical flow is the process of finding a mapping between the 
fixed and moving image that relates in a quantitative manner how image intensity 
information has changed between the two images. In theory both images are regarded as 
part of one mathematical function where spatial changes have occurred in the time 
between acquisitions transforming one image into the other. The optical flow is a vector 
field consisting of the changes in spatial coordinates. These vectors can be thought of as 
“optical velocity” vectors showing the direction of image intensity flow.  
A well-known method for estimating optical flow is the classical Horn and Schunck 
algorithm [99]. Here the optical flow field is found by minimizing a cost function that 
consists of an intensity term and a term penalizing non-smooth optical flow fields. The 
Horn and Schunck algorithm is available to radiation oncology community through the 
DI-ART platform in public domain[100]. The optimization is based on the calculus of 
variations. Because the Horn and Schunck method performs a global optimization it is 
able to produce very smooth transformations. The method was used for estimating intra-
thoracic tumor motion by Guerrero et al.[101]. Further the Horn and Schunck algorithm 
was found to be the best performing algorithm for dose warp accuracy in stereotactic 
irradiations and also the best performing algorithm in low contrast DIR accuracy studies 
using a deformable gel which played the roles of both a dosimeter and image study set 
[102-104] 
An invertibility term can be added to the Horn and Schunck method as done by Yang et 
al.[105] for obtaining inverse consistent registration (that is registration of moving image 
to the fixed image is the same as the inverse transformation of the fixed image to the 
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moving image, the details of inverse consistency are discussed in next chapter). A 
different approach than the global optimization performed by Horn and Schunck was 
taken by Lucas and Kanade [106] which is also available to the radiation oncology 
community through the DI-ART package[100]. Here an assumption of constant flow in a 
window around the pixel being considered was chosen which can be solved by the least 
squares method. The Lucas and Kanade method leads to a registration result which is of a 
more local nature in that the information about displacements at edges does not propagate 
through areas of uniform intensity. 
The two optical flow estimation methods mentioned above as well as the Demons method 
by Thirion have become the basis for a variety of deformable registration models based 
on non-parametric mode and have been used widely in radiation oncology community for 
a variety of clinical applications. 
Some authors have used calculus of variations in their work on DIR. For example Lu et 
al.[107] used calculus of variations to represent the minimization of their registration cost 
function as a set of elliptic partial differential equations  and validated the method on 
lung and prostate CT images. For applications in  head and neck, Zhang et al.[108] used 
these variational methods in implementing an atlas based segmentation by automatically 
delineating volumes of interest on 32 CT images from 7 different patients. 
3.5 Optimization methodologies 
Optimization refers to the manner in which a transformation function is adjusted to 
improve image similarity metrics discussed in sec 3.2.  A good optimizer can be thought 
of as one which finds the best possible transformation between source and fixed image in 
a quick and robust manner. Deformable image registration as discussed before is in 
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general an ill-posed problem.  There can be many deformation vector fields (DVF) in a 
non-parametric registration resulting in the same deformed image and thereby resulting in 
the same cost value as calculated by the chosen similarity measure. Therefore the 
similarity metric is usually combined with a regularization term. For parametric 
transformations the regularization is often achieved using a combination of a 
regularization energy term on the parameters and the properties of the parameterization 
function itself. Other transformations (like RBFs) function as interpolators and work by 
providing a smooth interpolation of prescribed displacements (the matching of 
landmarks). 
For non-parametric methods the smoothness of the resulting transformation 
is dependent  on the regularization chosen. This is related to the harmonic energy of the 
deformation vector field which is inversely proportional to the smoothness of the DVF. 
The details of harmonic energy of a deformation field are discussed in next chapter. For 
some non-parametric methods the regularization imposed is an implicit result of a search 
strategy instead of a term included in the cost function to optimize. 
3.5.1 Hierarchical approaches 
Most practical implementations of image registration methods utilize some kind 
of Hierarchical coarse-to-fine approach. Several possible approaches exist as discussed in 
Ref[109]: 
Multi-resolution approaches:  
The deformation is first approximated on low resolution versions of the images to be 
registered. The result of this coarse registration is then used as a starting point for a 
registration at a higher resolution. This continues until the deformation has been 
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approximated at the highest resolution. A multi-resolution strategy enables us to 
systematically handle modes of deformation at different scales. By finding a 
minimizing transformation at a low resolution there is a better chance of avoiding local 
minima at a higher resolution. This approach is used in the commercial DIR platform 
Mim Software [110]. 
 It should be noted that most DIR algorithms use different registration methods of 
increasing complexity as part of the hierarchical approach.  Almost every deformable 
registration method requires an initial global (rigid or affine) registration to be made that 
reduces the parametric search space before the deformable model is invoked. 
3.5.2 Optimization methods for parametric registration models 
For parametric methods a number of numerical methods can be used for optimization 
of the cost function. Gradient descents (GD), conjugate gradients (CG), etc… are 
commonly used optimizers for parametric models. 
A key ingredient in efficient optimization of a cost function is how efficient 
it is to compute the derivative of the cost function with respect to each of its parameters. 
If these derivatives cannot be found analytically they may be estimated using finite 
difference approximations. 
3.5.3 Optimization methods for non-parametric registration models. 
The non-parametric deformation models discussed before often needs a method to solve 
the Partial differential equations (PDEs) that arise from various models (Demons, 
Viscous fluid etc...) There are two primary methods to solve PDEs, the finite element 
method and finite difference method. The finite element method solves the PDEs by 
approximating the solution using a mesh to describe the volume and in general leads to a 
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better solution in more complex geometries because the mesh can be made flexible. The 
finite element methods are computationally more intensive. 
On the other hand the finite difference method approximates the PDEs and a solution is 
found by finite difference. These equations can then be solved by assigning appropriate 
boundary conditions applicable to a particular deformation model. 
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Chapter 4 
A framework for deformable image registration validation in radiotherapy clinical 
applications 
This chapter focuses on the details of DIR verification in the context of radiation therapy 
clinical applications. The DIR verification scheme proposed as part of this chapter was 
published in Journal of Applied Clinical Medical Physics, Ref [18].  
4.1 Introduction: 
Image Guided Radiation Therapy (IGRT) has become a widely used treatment modality 
in recent past with advanced treatment processes. IGRT requires daily or frequent 
imaging which can lead to treatment planning modification decisions based on patient 
specific anatomical variations as quantified by the imaging. However, routine IGRT in 
most clinical departments uses only the vendor supplied rigid registration matching 
between original treatment planning CT (kvCT) and the daily imaging study set.   
Deformable image registration (DIR) studies have been advocated to more accurately 
quantify these anatomical and biological variations [111]. Deformable registration is 
essential to map the position of each voxel to a reference CT image for dose tracking and 
to ultimately practice adaptive radiotherapy [6, 9] . The accuracy of deformable 
registration is particularly important in Intensity Modulated Radiation Therapy (IMRT) 
and adaptive radiotherapy that deliver differential doses to different parts of the tumor 
and organs at risk which then sum to a uniform dose. The existing methods of deformable 
image registration can be classified broadly into two categories, parametric or model 
based( B-Splines [86], Thin plate splines [112], linear elastic finite element [90] etc..) and 
non-parametric methods ( optical flow [93], viscous fluid [97],  etc..) 
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There have been many techniques proposed to validate the accuracy of various DIR 
algorithms [95, 108, 113-119].  All DIR evaluation procedures require the use of 
evaluation data and validation methods. Considering the evaluation data one can separate 
the methods into two groups: a. those using real patient image data and b. those using 
phantom image data. In the first set of methods the authors use real patient image that 
they deform artificially to create the reference and the test study. Alternately multiple 
imaging acquisitions on different time moments where changes in anatomy are clearly 
visible and anticipated (e.g. re-planning scans or cone beam CT scans) are used. The use 
of deformable phantoms has also been explored to validate the accuracy of DIR. 
However phantoms as described in [120-122] cannot be routinely used in most busy 
clinical departments because of the lack of resources and time required to build and test 
these phantoms. Further, it is not practical to build a phantom that will be sophisticated 
enough to simulate all anatomical deformations that can occur in a clinical environment.  
It has also been suggested that the presence of uniform intensity regions in the phantom 
images as opposed to more intensity gradients in clinical CT images may limit the 
applicability of phantom tests in DIR verification [113]. 
The validation methods often include using landmark points in regions of interest, as a 
surrogate tool in verifying accuracy of DIR. A frequent problem with this technique is 
locating the landmark points, which in real patients anatomy can be time consuming and 
difficult to identify markers in low contrast regions. The contour based evaluation is 
useful qualitative verification in contour propagation and also for inspecting anatomical 
difference among images. Although contour propagation techniques seem to provide a 
more efficient way of validation compared to markers, including changes in shape 
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volume and location of a structure, they often do not confirm that the volume within the 
contour has been properly registered.  
In this work we describe a commercial software tool kit, ImSimQA (Oncology Systems 
Limited, UK) which can serve as a virtual deformable QA tool by simulating clinically 
observed organ deformations in routine IGRT. In contrast to previous years where 
deformable registration algorithms where available only in a research based setting, today 
several commercially available products are available. Most of these commercially 
available products are “black boxes” in that very little information is known to the 
medical physicist regarding the overall system accuracy of the implemented algorithm 
and what the limitations of the deformable registration algorithm could be for a given 
clinical situation. This is particularly true for IGRT since different organs exhibit varying 
levels of deformation over the course of radiation therapy. Presumably the algorithm will 
have different registration settings to accurately register the images over these varying 
clinical scenarios. Therefore, it is critical that some quantitative validation of the system 
accuracy of the implemented algorithm and its potential limitations in the commonly 
encountered IGRT clinical situations exists [123].   
This work describes a complete set of metrics and tools and a practical framework to 
evaluate a deformation field and highlights the importance of selecting an appropriate 
evaluation tool which is dependent on a given clinical deformation. This will ensure that 
a false positive conclusion is not reached in validating a particular DIR algorithm.  
4.2 MATERIAL AND METHODS.  
In order for a complete and thorough validation of DIR performance in a clinical 
environment the following three characteristics were examined in this study 
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4.2.1 Anatomical correspondence:  
Anatomical correspondence between original and deformed image sets can be identified 
using markers or contours defined by the users. This validation is important because in 
radiotherapy clinical applications, the tumor and organs at risk (OAR) volume changes 
and consequently the partial volume dose received by these structures. The magnitude 
and location of these changes dictate the need for adaptive radiotherapy. Hence the 
accuracy of DIR in relation to this is evaluated in this paper by quantitatively comparing 
the original tumor and OAR segmentation with those obtained from warping the RT 
structures with the Deformation Vector Field (DVF) derived from registration. Dice 
Similarity coefficient, Hausdorff distance and average surface distance were used as three 
metrics to evaluate the accuracy of tumor and OAR segmentation and spatial overlap 
index.  
4.2.2. Deformation field:  The physical characteristics of the deformation fields should 
be investigated. This is because recent applications in Adaptive Radiation Therapy (ART) 
have used the deformation fields arising from image registration process to warp the RT 
Dose and display a deformed dose [124-127]. Hence some quantitative information on 
the physical characteristic of deformation fields is necessary for clinical implementation 
of ART. It is known that matching of structures based on their intensities alone is not a 
sufficient condition to produce physically achievable deformations[128].  
In this work we used a number of methods to evaluate the characteristics of the DVF. 
One of the key methods reported in the literature is the concept of inverse consistency 
[129-131]. Inverse consistency between two images A and B are evaluated as follows in 
this paper. Image A is deformed to match image B, and image B is separately deformed 
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to match image A using two different algorithms. A perfect inverse consistent algorithm 
will produce a true inverse DVF when the roles of source and target images are switched. 
However in practice this is not the case. The inverse consistency error (ICE) between 
forward and inverse registration is calculated by compositive accumulation of forward 
and inverse deformation fields. The magnitude of compositive accumulation will be zero 
for perfectly inverse consistent algorithm. The details of compositive accumulation are 
discussed in the next section. The disadvantage of inverse consistency method is that a 
zero value for ICE is a necessary but not sufficient condition for an accurate algorithm as 
errors in one DVF may cancel with errors in the other to yield a net zero value during 
composition of two deformation maps [129].   
Diffeomorphism is a necessary condition for deformation fields to be physically feasible 
[132]. This property is related to the jacobian of the deformation field. Negative 
jacobians indicate unrealistic physically unachievable organ deformations as organs can 
only be compressed and deformed but cannot undergo non invertible spatial 
transformations like folding of structures [133, 134].  This is the primary advantage of 
diffeomorphic demons over B-Splines algorithm as the jacobian is always non-negative 
in the former.  
In this study, we compute the determinant of the jacobian of the deformation field as a 
criterion for validating physical behavior of deformation. The harmonic energy of the 
deformation field is used to quantify the regularity of the spatial transformation obtained 
by the deformable registration process [135]. The harmonic energy of B-Splines and 
diffeomorphic demons algorithms are calculated in this study to distinguish displacement 
fields based on regularity of the transformation. 
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4.2. 3. Image characteristics: Comparison between original and deformably registered 
images to provide a measure of how well the deformation is recovered in the entire image 
voxel space. 
Mean Square Error (MSE) between registered and original image was computed as a 
measure of how well the deformation is recovered in the entire image voxel space.  
Three clinically relevant examples from Prostate, Head & Neck and Lung case are 
presented and the accuracy of DIR is evaluated using various methods described above 
and the relative merits of these are discussed. 
The workflow and evaluation methods for DIR accuracy used in this paper are 
summarized in the flow chart below.for DIR accuracy used in this paper are summarized 
t b 
The workflow and evaluation of DIR in this paper is outlined in the flow chart below.  
 
 
 
 
 
 
 
 
 
 
 
STEP A. Prepare CT Te t Cases using ImSimQA 
Prostate Head & Neck Lung 
Apply Local Deformation 
 
Apply Global Deformation Apply Local Deformation 
Products 
1. Warped CT images  
2. Warped RT structures 
3. Direct and inverse ImSimQA deformation field 
 
STEP B. Apply DIR between Original and Warped image sets in both 
forward and inverse direction using 3DSlicer 
Diffeomorphic Demons algorithm 
 
B-Splines algorithm 
 
a. Prostate original. vs. warped 
b. Head & Neck original. vs. warped 
c. Lung original. vs. warped 
a. Prostate original. vs. warped 
b. Head & Neck original. vs. warped 
c. Lung original. vs. warped 
Products 
1. Direct and inverse deformation field (B-Splines & Diffeomorphic Demons) 
2. Warped RT structures using above deformation fields 
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4.2.4. Overview of methods of deformation in ImSimQA: 
A brief description of the deformation process used in ImSimQA to warp the images to 
produce clinically observed organ deformation is presented below. In ImSimQA, there 
are two choices for the geometric deformation of the image data.  Both implementations 
are based on the Radial Basis Function approach with different kernel functions. For the 
global deformation of the data, the Thin-Plate Spline (TPS)[136] kernel was utilized and 
the Compact Support Radial Basis functions (CSRBF)[137] as the local deformation 
scheme. Both algorithms have a closed form solution and their parameters can be 
computed by solving a linear system through QR decomposition.  
Thin-Plate Splines 
In ImSimQA the algebraic solution of Bookstein [82, 136] is followed which treats the 
TPS solution as an interpolation problem. In order to perform the deformation, two sets 
of landmark points must be chosen which will be referred to as the source points (SP) and 
the target points (TP) from so on. In case of a 2D image, the surface of the image is 
treated as a 2D grid with each yx, of the image coordinates being a part of the image 
grid. The SP and TP are manually inserted on the grid. The vectors, with their origin at 
STEP C. DIR Evaluation Scheme using 3DSlicer 
I. Deformation Field 
 
II. Anatomical 
Correspondence 
III. Image Quality 
 
1. Inverse Consistency 
Error 
2. Jacobian 
3. Harmonic Energy 
 
1. Dice Similarity 
Coefficient 
2. Hausdorff Distance 
3. Average Surface 
Distance 
 
Root Mean Square Error 
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the SP coordinates and directed at the corresponding TP coordinates, show the 
deformation direction of the grid. In order to solve this problem a mapping function 
),( yxf is found that will map the SPs to TPs by deforming the underlying grid. 
Given a set of n corresponding points on a D  dimensioned grid, the TPS warping is 
described by )1(  DnD parameters which include )1( DD  global affine transform 
parameters and Dn  coefficients as the RBF parameters. As an example in D2 space, for 
any 
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Where P  are the target points,  
22 log)( dddU   is the TPS kernel and d  the distance 
between SP and TP. W  are the parameters for the non-rigid part of the function and A  
the parameters of the rigid part. The separation of the rigid and the non-rigid parameters 
is done through QR decomposition and the solution can be extended in any dimension. 
Compact Support Radial Basis Functions (CSRBF) 
The TPS deformation affects the whole image and is characterized as a global 
deformation procedure. For applications which need local deformation, the CSRBF 
model is implemented. The locality effect of the CSRBF is adjusted by calibrating a 
scaling parameter. The algebraic solution to the CSRBF is the same as the TPS with only 
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difference the RBF kernel used. The CSRBF kernel is a Wendland function[83] 
constructed from piecewise polynomials. In ImSimQA the kernel utilized in the CSRBF 
implementation is: 
lddR )1()(     
where d  is the distance between the SP and the TP, 132/  kDl . D  is the 
dimension space of the problem, and k is a smoothing parameter (0 in ImSimQA). In this 
way R  returns a value for 10  d otherwise returns 0. The deformation is applied in a 
radius around the SP. There is a spatial scaling parameter 0a  for adjusting the radius. 
Then the CSRBF is scaled as )/()( adRdRa   and in this way the radius of the 
deformation is adjustable.  In both algorithms anchor markers can be placed inside the 
dataset in places where the restriction of the deformation is needed. If the SP and the TP 
are identical then deformation around these markers is restricted. By default, in both 
algorithms there are anchor points at the border of the dataset, four in the 2D case and 
eight in the 3D case. This is done to avoid excessive warping of the original dataset.   
 Simulating and storing deformations in ImSimQA 
As mentioned above, ImSimQA can perform global and local deformations or a 
combination of both. The deformation algorithms are controlled using marker points that 
are user-defined and can be freely positioned on the image set. The deformation 
workflow is performed in the following work flow. 
a. The user defines the source control marker points and enables the local (CSRBF) 
or global (TPS) deformation procedure. The direction of the deformation is given by 
translating and rotating the control points individually or as a group of points. The control 
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points can be moved in three dimensions. For the deformation procedure to start, the 
source and target positions of the control points are used.  
b. A deformation field comprising a three component vector value at each voxel is 
generated.  
c. The source image is then warped using this deformation field. Tri-linear 
interpolation is used to correct floating voxel locations during image warping.  
For more complex deformations, one can combine TPS over CSRBF deformations and 
vice versa. In this way the new data set is a deformation based on a complex calculation 
of deformation. The final deformation field is composed as the addition of both 
deformations which can be applied only once on the original image set.  
For documentation and testing purposes it is possible to export the deformed image set 
(as a new DICOM set), the deformation field as a binary 3D grid and also deformed RT 
structures as a new RT-Structure.   
In Figures 4.1a -f, a simulated deformation example is illustrated. The original axial 
image is a virtually generated phantom CT image.  Figure 4.1a shows the axial image of 
quasar phantom [138] The red marker points in figure a illustrate the original marker 
location. In figure 4.1b, the target location of the markers is a result of marker translation 
and rotation. Target location and source position are linked with a line. The global 
deformation (TPS) result is shown in figure 4.1c while the local deformation (CSRBF) 
result is shown in figure 4.1d. For both deformations the same source and target points 
were used. The magnitude of the deformation field vectors on an axial slice for the TPS 
and CSRBF are shown in figure 4.1e & f respectively. As expected, one can observe a 
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much wider area of iso-contours for the TPS deformation. For the CSRBF, the 
deformations are limited into a small radius around the target marker location.  
 
Figure 4.1a:  Axial image of quasar phantom with original marker points. 
Figure 4.1b Axial image of quasar phantom with target marker points. 
Figure 4.1 c:  Axial phantom image after applying the global (TPS) deformation 
algorithm. 
a b 
c d 
e f 
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Figure 4.1d: Axial phantom image after applying the local (CSRBF) deformation 
algorithm. 
Figure 4.1e Magnitude of deformation vector field from TPS on the axial view 
Figure 4.1f Magnitude of deformation vector field from CSRBF on axial view 
 
4.2.5. Clinical rationale and description of applied known deformation in each 
anatomical site: 
a) Prostate: In prostate IGRT, deformation of the prostate due to variations in rectal 
filling is commonly observed. The need for adaptive radiation therapy for prostate cancer 
due to inter and intra fraction motion is well documented in the literature [107, 139-148].  
We applied a known deformation in the ImSimQA to mimic a distended rectum and 
introduce rectal gas in the synthetically deformed image. This in turn deforms the 
prostate as routinely seen in prostate IGRT. 
For the CT series of the prostate case (512 × 512 ×74 (median) voxels; 0.86 × 0.86 × 5.0 
mm
3
) images were acquired on a SIEMENS Sensation 16 CT scanner which included the 
RT structures used during DIR evaluation. It should be noted all the applied deformation 
in this study is fully three dimensional although only a particular slice view is shown for 
illustration. Figure 4.2 below shows axial view of original kvCT image with RT 
structures, figure 4.3 indicates applied deformation from ImSimQA and figure 4.4 shows 
the changes in RT structures from the applied ImSimQA DVF when compared to original 
RT structures. 
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Figure 4.2: Axial view illustrating the local deformations introduced in the prostate 
and rectal region and gas pocket in the rectum. 
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Figure 4.3: Axial view of the prostate kvCT image with original RT structures namely 
bladder, prostate, rectum and pelvic bones. 
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Figure 4.4: Contour changes in prostate, bladder and rectum from the applied 
ImSimQA DVF when compared with original segmentation of these structures. Solid 
figures refer to original segmentation done by radiation oncologist on kvCT image and 
dotted figures refer to the deformed volumes due to the applied deformation. 
b) Head & Neck: 
There are significant changes in patient anatomy during the course of Head and Neck 
IGRT treatment that are related to decrease of tumor and nodal volumes, patient weight 
and alteration in muscle and fat distribution with an average tumor volume reduction of 
70% of its initial volume at the end of treatment[149]. Similarly, the parotid glands also 
undergo significant volume reduction with an average reduction of 49.8 % and a 
translation of 8.1 mm upon completion of treatment [150]. 
The changes occurring due to patient weight loss could have a significant impact on 
Organs at Risk (OAR) like the parotids, since these structures can now be in the high 
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dose gradient area and tumor could be under dosed.  Adaptive radiotherapy has been 
advocated to mitigate such volume changes [151-156]. We applied a global deformation 
on the ImSimQA software to change the patient neck flexion and studied the deformable 
registration algorithm to track these changes as shown in figs 4.5 a, b c. The induced 
deformation does not correspond to inter fraction variation that occurs during routine 
head and neck IGRT but rather relates to a clinical scenario where the patient was treated 
previously with a completely different neck position and is now being evaluated for 
radiation therapy in the same area in a different treatment position. The induced 
deformation significantly altered the nasal cavity, the alignment of vertebral body, spinal 
cord and skull in comparison with the original image.  
For the CT series of the head and neck case (512 × 512 ×112 (median) voxels; 0.94 × 
0.94 × 3.0 mm
3
) images were acquired on a SIEMENS Sensation 16 CT scanner which 
included the complete set of RT planning structures. Figure 4.5 d shows the sagittal view 
of original kvCT image with associated RT structures, figure 4.6 shows the deformed 
image from ImSimQA after applying the neck flexion and the and the warped RT 
structures as result of applied ImSimQA DVF when compared to original RT structures. 
  89 
 
Figure 4.5 a,b,c. Original image of skull, rotated image of skull and overlay of original 
and rotated skull respectively  demonstrating the applied neck flexion for validating DIR 
 
un-deformed image 
of skull 
a 
Skull rotated 
counterclockwise in 
deformed image 
b 
c 
Overlay of deformed 
and un-deformed image 
  90 
 
Figure 4.5 d: Sagittal view of the original head & neck CT image with the associated RT 
structures brain stem, cord, larynx and mandible. 
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Figure 4.6:Sagittal view of the head and neck image from the applied global deformation 
mimicking a large neck flexion. The skull is rotated counter clockwise. The deformed RT 
structures due to the applied deformation are displayed as dotted figures. 
c) Lung: 
Respiratory motion of the order of 1 cm has been observed for tumors close to the 
diaphragm [157, 158]. We introduced a deformation in ImSimQA to mimic dataset from 
inhale and exhale breathing phases of 4DCT. Deformable registration attempted to track 
this worst case scenario.  
In addition to the lung volume changes, we introduce contrast changes in the image to 
assess the quality of DIR during variable contrast enhancement.  The original kvCT 
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images have contrast in the scan, while in the synthetically deformed images from 
ImSimQA the contrast has been taken out. This example was chosen to highlight the 
limitations of diffeomorphic demons algorithm when the intensities of identical tissues 
and organs are different in the two images.  
For the CT series of the lung case (512 × 512 ×123 (median) voxels; 0.98 × 0.98 × 3.0 
mm
3
) images were acquired on a SIEMENS Sensation 64 unit which included the 
complete set of RT planning structures.  
Figures 4.7, and 4.8, below show the coronal view of original kvCT image with contrast, 
and the coronal image from ImSimQA without contrast showing diaphragm motion and 
lung volume changes. 
 
Figure 4.7: Coronal view of the original lung kvCT image showing the lung contours 
and contrast in scan. 
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Figure 4.8: Coronal view of the same lung kvCT image illustrating the applied local 
deformations on the diaphragm and the changes in lung contour associated with that. 
This mimics an inhale and exhale breathing phase of respiratory cycle. The contrast is 
also taken out of this image to validate DIR during variable contrast enhancement. 
4.2.6. Deformable Image registration 
The Insight Segmentation and Registration Toolkit (ITK) was used to perform (a) free-
form parametric deformable registration using a cubic B-Splines [159] and (b) non-
parametric registration using diffeomorphic demons. The DIR and all the analysis tools 
described in this work were integrated into open source platform 3D Slicer [17]via 
custom developed modules. We used the Mattes Mutual Information (MI) metric [160] 
with an evolutionary algorithm followed by gradient descent optimizer for optimization 
[161].  The images are initialized to line up their centers. The evolutionary optimizer 
  94 
works by searching for the minimum metric value by generating random samples about 
the current location in parametric space and iteratively growing or shrinking parameters 
of previous iteration to hone in on the optimum. This process is fairly resilient to noise. 
After this, a regular step gradient descent optimization is performed, with the 
transformation parameters incremented in the direction of gradient. The increment is 
determined in a bipartition manner until it converges on the minimum of the metric. 
Registration is performed in 3 phases: rigid, followed by affine, followed by deformable 
registration. A control point spacing of 60 (pixels), 50 maximum iterations and 10% of 
the image pixels for metric evaluation were used in this study during B-Spline 
registration to achieve optimal balance between quality of DIR and run time of 
registration. Registration was completed in 15 minutes on a Windows 7, 64 bit operating 
system running on Intel quad core 2.8GHz processor with 8GB RAM. 
The same manually deformed images are also registered using diffeomorphic demons 
[162]to provide a smooth and invertible transformation. In general, for non-parametric 
registration methods such as diffeomorphic demons used in this study, the registration is 
expressed as an objective function comprising of an image term and regularization term. 
The image term may be the difference in intensities of two voxels (optical flow as in 
demons) while the regularization term keeps the deformation field well-behaved. This is 
usually done by smoothing the deformation field with a Gaussian at each iteration to 
ensure that it is well-behaved. 
 Details on the implementation of this algorithm and its advantages over Thirion’s 
demons algorithm [93] are discussed in literature[162]. A diffeomorphism by definition 
preserves the topology of objects in the image. In other words, it prevents folding of 
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structures onto itself. Therefore the jacobian is always non-negative. This is a good 
property to have for medical image registration. The second important property of 
diffeomorphism is that they are guaranteed invertible by definition. 
Registration is typically faster and takes about 10 minutes when using diffeomorphic 
demons algorithm using the same hardware platform as previously described. 
4.2.7. Evaluation Scheme: 
I. Deformation Field 
a. Inverse Consistency: 
 For each anatomical site the original kvCT and the synthetically deformed image from 
ImSimQA were used to test inverse consistency of B-Splines and diffeomorphic demons 
algorithms. The two images are registered separately both in the forward and inverse 
directions. A perfect inverse consistent algorithm in theory should give a deformation 
map which is a true inverse of one another. However in reality this rarely occurs because 
most algorithms do not produce true inverse deformation maps since deformable 
registration is inherently degenerative and multiple solutions may exist for a given image 
matching problem.  
We use the concept of compositive accumulation to quantify the inverse consistency 
error. The details of compositive accumulation as discussed in [129, 163] are summarized 
below. 
The concept of compositive accumulation is used to quantify the inverse consistency 
error. The warping by a deformation vector field D is associated with its corresponding 
transformation operation Δ, such that Δ   Id + D, or Δ(x)   x + D (x), where Id is the 
identity transformation such that I d(x) = x.  Mathematically given two images A and B 
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during DIR, the objective is to find a deformation vector field D such that warping of 
image B by D is close to original image A or  A = B ο Δ. 
 If D1 and D2 are two deformation fields, a single warping by compositive addition of D1 
and D2 is equivalent to successive deformation of an image by D1 and then followed by 
D2.  
The warping by a field D is equivalent to the composition with its corresponding 
transformation ∆. One can then use the composition of function in order to replace 
successive warpings (i.e. by different displacement fields) with a single warping (i.e. by 
an equivalent displacement field). Mathematically, this compositive operation denoted as 
⊕, is defined as follows 
 D1 ⊕ D2 = ∆1 ◦ ∆2 − Id. 
By construction, the deformation operation linked to the displacement field D1 ⊕ D2 is 
therefore ∆1 ο ∆2. The operation ⊕  has some interesting and useful properties. First, the 
neutral is of course obtained with the null displacement field, i.e. D ⊕ 0 = 0 ⊕ D = D. It 
can be shown that the associative relations (D1 ⊕ D2) ⊕ D3 = D1 ⊕ (D2 ⊕ D3) = D1 ⊕ 
D2 ⊕ D3 for three displacement fields D1, D2 and D3. 
The composition of two deformation fields makes use of the operation ο. This means  
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D1  D2 = D2 + D1 o D2, meaning that that D1  D2 is equivalent to summing 
deformation field D2 with the field D1 warped by D2 [163] . A simple proof is presented 
below. 
D1  D2 = Δ1 ο Δ2 – Id. By construction the deformation operation linked to D1  D2 is 
Δ1 ο Δ2. 
Since D1 o D2 = D1 ο ∆2, and D = ∆ − Id, one can easily see that: 
D2 + D1 o D2 = D2 + D1 ο ∆2 
= ∆2 − Id + ∆1 ο ∆2 − Id ο ∆2 
= ∆1 ο ∆2 − Id 
= D1 ⊕ D2.
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Further the compositive addition operation  is associative for three deformation fields 
D1, D2 and D3 meaning (D1  D2)  D3 = D1  D2  D3) = D1  D2  D3 
 For the warp, we use a linear interpolator, i.e. we add the right field to the interpolated 
left field for that pixel as the resulting point x will not land exactly in the grid. 
For purposes of inverse consistency, if D1 and D2 are deformation fields from forward and 
inverse registration, the compositive accumulation of forward and inverse deformation 
fields will yield the inverse consistency error (ICE). If the deformation maps are true 
inverses, this composition will yield zero. The L2 norm (absolute magnitude) of the 
composed fields is used to quantify the magnitude of inverse consistency error. 
Further, ICE between the DVF arising from DIR and the synthetic DVF generated from 
ImSimQA software which was used to produce clinically relevant organ deformation was 
evaluated. The ImSimQA can also output inverse DVF of the applied deformation. This 
DVF was compared with the DVF generated from the inverse registration process where 
the roles of source and target images were switched. A compositive accumulation of the 
ImSimQA DVF and the DVF from registration (B-Spline and diffeomorphic demons) 
was done to quantify the ICE between DVFs. If the results of DIR produced a DVF 
which is the exact inverse of applied synthetic DVF in ImSimQA, then this composition 
of DVFs will be zero. The L2 norm of the composed DVFs is computed to quantify the 
ICE between DVFs.  
b. Determinant of jacobian of the deformation Field: 
The jacobian of the deformation field gives information about the image transformation 
consistency[134, 164]. The jacobian is a matrix given by the first partial derivatives of 
the transformation with      
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where     is kronecker delta (                           and Di is the ith component 
of deformation field. 
We computed the determinant of the jacobian of the deformation field in this study to 
validate the physical behavior of deformation. A negative determinant indicates 
singularities in the field and corresponds to a physically unrealistic organ deformation.  A 
determinant greater than 1 indicates expansion at that location while a value less than 1 
indicates contractions. 
c. Mean Harmonic Energy of the Deformation Field:  
The harmonic energy captures the non-linearity of the warp i.e. deviation from an affine 
transformation. The mean harmonic energy is defined as the frobenius norm of the 
jacobian and is inversely proportional to how smoothness of the deformation field [135]. 
The harmonic energy at a voxel can be defined based on the first order partial derivatives 
of the deformation field as follows: 
HE (D) = ½      
      
   
      
 
       
where Ʋ is the domain of the deformation field. 
 
II. Anatomical correspondence: 
In radiotherapy clinical applications the accuracy of tumor and organ at risk (OAR) 
structures is of paramount importance. Ultimately the changes in the shape and volume of 
these structures and consequently the dose received by them dictate the need for adaptive 
radiation therapy. 
We use the Dice similarity coefficient, Hausdorff distance and average surface distance 
as three metrics to evaluate the accuracy of tumor and OAR for each anatomical site 
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before and after DIR. These metrics have been previously used to compare segmentations 
in radiotherapy applications and are described below [96, 165-167]. The ImSimQA DVF 
was used to warp the original RT structures in addition to CT images. The registration 
DVF from both algorithms was then applied to these RT structures.  If the results of DIR 
were perfect then the RT structures before and after DIR would be the same. The degree 
of mismatch indicates the quality of DIR from an anatomical correspondence perspective.  
a. Dice Similarity Coefficient:  
The metric computes the number of pixels that overlap between the two volumes and 
normalizes it by the half the sum of the number of non-zero pixels in the two volumes. 
The result is a value between 0 (no overlap) and 1 (perfect overlap) as shown in fig 4.9 
 α = 
          
        
 
where A is the gold standard segmentation which in our case refers to segmentation in 
kvCT fixed image, B is the segmentation mapped from the deformably registered image. 
The metric is symmetric and is sensitive to both differences in scale and position. While 
volume overlap is a good indicator of mismatch, it is a poor indicator of shape since is 
not a measure of distance and hence the following metrics are also evaluated to assess the 
overall accuracy. 
b. Hausdorff distance:  
The Hausdorff distance [168] is defined as the maximum of the closest distance between 
two volumes where the closest distance is computed for each vertex of the two volumes. 
The hausdorff distance H(A,B) between 2 sets of points A = {a1, .., am} and B = {b1, .., 
bm} is given by 
H(A,B) = max(h(A,B), h(B,A)) 
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where h(A,B) = maxa€Aminb€B|| a-b||  
h(A,B) is the directed hausdorff distance from A to B, which unlike the hausdorff 
distance is not symmetric. 
h(A,B) identifies the point a ∈ A that is farthest from any point in B, and then measures 
the distance of A to its nearest neighbor in B. The point sets A, B in our case, are the 
centers of the non-zero pixels in the gold standard (original kvCT) and deformably 
registered segmentations. Thus, the hausdorff distance is a measure of the maximum 
distance between two surfaces as shown in fig 4.9 a. It obeys all four properties of metric 
spaces and distance functions. 
– Identity: H(A,A) = 0 
– Positive semi-definiteness: H(A,B) = 0 
– Symmetricity: H(A,B) = H(B,A) 
– Triangle inequality: H(A,C) = H(A,B) + H(A,C) 
The metric is very sensitive to outliers since the most mismatched point is the sole 
determining criteria of the distance.  Some authors use 95% Hausdorff distance (95%HD) 
as the outliers are rejected in 95%HD. 
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Fig 4.9a Hausdorff Distance is the maximum perpendicular distance between closest 
points from two contours of registered images. Black line represents an external contour 
from one image and gray line represents an external contour from another registered 
image. Small circles represent corresponding closest points between each contour. 
Hausdorff distance represents the distance between small circles at black arrow. b) Dice 
coefficient similarity (DSC) is an index of overlap of two different volumes. Solid black 
line represents a volume from one image and dotted black line represents a volume from 
another image after registration.  DSC is a value between 0 (no overlap) and 1 (perfect 
overlap). (Diagram above adapted from Reference [169]) 
c. Average Surface Distance:  
This metric mitigates the outlier problem exhibited by the Hausdorff distance. The metric 
is the average of the absolute distance from each surface pixel in one image to its closest 
point on the other image. This metric is not symmetric, although it satisfies the positive 
semi-definite and identity properties of distance metrics. 
4.9 a 4.9 b 
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M (A, B) = 
     €          € 
   
 
 
III. Image Characteristics: 
a. Mean Square Error: 
We used metric Mean Squared Error (MSE) to define the extent of mismatch between the 
original image A and the deformably registered image B which is the normalized square 
difference between the two images A and B [170] . If f (n) and g (n) represent the value 
(intensity) of an image pixel at location n. The MSE between  
f (n) and g (n) is defined as: 
MSE  = 1/N Σn {f (n) - g (n )}
2
,    
where N is the total number of pixel locations in f (n) or g (n). 
For a perfect image match between images A and B the MSE error is zero. 
The error is reported as Root MSE in this paper where Root MSE =      
4.3 Results: 
The results of the accuracy of DIR evaluation in three clinical cases namely prostate, 
head & neck and lung are presented below 
4.3.1 Inverse Consistency Error: 
Table 4.1 below lists Inverse Consistency Error (ICE) between various DVFs used in 
DIR and ICE between applied ImSimQA DVF and DVF from DIR for the 3 anatomical 
sites studied. 
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Table 4.1. Inverse consistency error of various DVFs and in comparison with ImSimQA 
DVF 
As an example for the prostate case, the DVF from diffeomorphic demons algorithm is 
overlaid on the original kvCT image for forward, inverse and compositive addition of 
forward and inverse DVFs is shown in figures 4.10, 4.11 and 4.12 respectively. Figure 
4.13 relates to the quantitative ICE described in Table4.1 (1.45 mm) for diffeomorphic 
demons algorithm for the prostate case. 
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Figure 4.10: Forward diffeomorphic demons DVF from the registration overlaid on the 
original prostate kvCT image illustrating the local changes due to the DVF. The field 
vectors are pointing outward. 
 
Figure 4.11: Inverse diffeomorphic demons DVF when the role of source and target 
images were switched from previous example, overlaid on the original kvCT image. The 
field vectors are pointing inward. 
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Figure 4.12: Compositive addition of forward and inverse demons DVF overlaid on the 
original kvCT image. If the algorithm was truly inverse consistent this composition would 
yield zero. The magnitude of this compositive addition is 1.45 mm in this example as 
discussed in Table 4.1. 
4.3.2 MSE, Jacobian and Harmonic energy of DVF 
Table 4.2 below lists Root Mean Square Error, Minimum jacobian and Harmonic Energy 
of deformation field for registration algorithms both in forward and inverse directions for 
all 3 anatomical sites: 
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Diffeomorphic 
Demons 
Forward 
25.9 11.8 0.05 0.12 187 51.9 0.32 0.0005 91.33 853.6 0.53 N/A 
Diffeomorphic  25.9 11.6 0.09 0.003 187 66.1 0.43 0.003 91.33 223.3 0.19 N/A 
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Table 4.2 Root Mean Square Error, Minimum jacobian and Harmonic Energy of 
deformation field for registration algorithms both in forward and inverse directions for 
prostate, head and neck and lung anatomical sites: 
4.3.3. Accuracy of RT Structures 
Tables 4.3, below evaluates the accuracy of RT structures for the prostate case, after DIR 
when compared to original segmentation done by the radiation oncologist  in kvCT ( used 
as the gold standard) for both diffeomorphic demons and B-Splines algorithms. This was 
done by applying the registration DVF to RT structures deformed by ImSim DVF. All the 
evaluation is done on the original fixed image (kvCT) coordinate system.  
Table 4.3 Accuracy of RT structures after DIR for Prostate 
Algorithm: Diffeomorphic Demons 
Anatomy 
 
Dice 
Similarity 
Coefficient 
Hausdorff 
Distance 
(mm) 
Average 
Surface 
Distance (mm) 
Prostate 0.85 15.9 2.3 
Bladder 0.93 11.1 0.78 
Rectum 0.79 12.6 1.2 
Femoral Heads 0.99 1.7 0.1 
Demons 
Inverse 
B-Splines 
Forward 
25.9 11.03 0.0006 0.88 187 80.8 0.014 0.53 91.33 68.1 0.000
5 
0.82 
B-Splines 
Inverse 
25.9 10.9 0.0005 0.87 187 51.2 0.005 0.58 91.33 69.2 0.000
4 
0.87 
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Mean values 0.89 10.3 1.1 
Algorithm: B-Splines 
Anatomy 
 
Dice 
Similarity 
Coefficient 
Hausdorff 
Distance 
(mm) 
Average 
Surface 
Distance (mm) 
Prostate 0.91 9.8 1.03 
Bladder 0.95 7.7 0.42 
Rectum 0.89 10.3 0.8 
Femoral Heads 0.99 1.2 0.1 
Mean values 0.94 7.3 0.59 
Table 4.4 below evaluates the accuracy of RT structures for head & neck case. Although 
by visually inspecting the images the registration seems to agree qualitatively (the skull 
and vertebral bodies matched after DIR) the contour comparison statistics are not 
clinically acceptable especially for organ at risk structures. This is primarily due to large 
neck flexion introduced as a known deformation in ImSimQA. Based on this analysis, 
auto registration of images when there is significant neck flexion should be evaluated 
with caution especially when there is a re-treatment being considered.  
Table 4.4  Accuracy of RT structures after DIR for Head & Neck 
Algorithm: Diffeomorphic Demons 
Anatomy 
Dice Similarity 
Coefficient 
Hausdorrf 
Distance(mm) 
Average 
Surface 
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Distance(mm) 
PTV Primary 0.85 8.9 1.8 
PTV Secondary 0.86 9.1 1.5 
Spinal Cord 0.51 12.2 2.4 
Right Parotid 0.84 4.7 0.8 
Left Parotid 0.77 6.6 1.4 
Brainstem 0.64 11.9 2.7 
Mandible 0.63 40.5 4.6 
Larynx 0.86 5.7 1.1 
Right Eye 0.74 7.5 1.8 
Left Eye 0.79 4.9 1.3 
Mean values 0.75 11.2 1.9 
Algorithm: B-Splines 
Anatomy 
Dice Similarity 
Coefficient 
Hausdorrf 
Distance(mm) 
Average 
Surface 
Distance(mm) 
PTV Primary 0.88 8.2 1.5 
PTV Secondary 0.87 8.6 1.4 
Spinal Cord 0.52 10.5 2.2 
Right Parotid 0.84 3.7 0.8 
Left Parotid 0.79 5.9 1.3 
Brainstem 0.52 9.7 3.9 
  110 
Mandible 0.7 13.6 1.9 
Larynx 0.86 5.7 1.1 
Right Eye 0.59 8.7 2.6 
Left Eye 0.83 4.7 0.93 
Mean values 0.74 7.9 1.7 
 
Table 4.5 below computes the accuracy of RT structures for the lung example involving 
variable contrast enhancement. The diffeomorphic demons algorithm produced improper 
displacement estimation in this case because of the difference in intensities of two images 
due to the variable contrast enhancement. The mismatch in RT structures is particularly 
relevant in heart, lung, bronchial tree and vertebral bodies as the hausdorff distance 
exceeds 10mm and the average surface distance is as large as 11.8 mm for heart. This is 
because diffeomorphic demons algorithm tries to match structures of same intensity 
which in our case does not correspond to identical anatomical structures due to the 
differences in contrast between two images. 
Table 4.5. Accuracy of RT structures after DIR for Lung 
Algorithm: Diffeomorphic Demons 
Anatomy 
Dice Similarity 
Coefficient 
Hausdorff 
Distance 
(mm) 
Average 
Surface 
Distance (mm) 
PTV 0.83 8.8 1.4 
Cord 0.95 4.6 0.2 
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Heart 0.37 56.7 11.8 
Lung 0.99 17.7 0.4 
Bronchial Tree 0.49 18 4.2 
Trachea 0.91 15 1.3 
Vertebral Body 0.92 10.3 0.2 
Mean Value 0.78 19.3 2.8 
 
Algorithm: B-Splines 
Anatomy 
Dice 
Similarity 
Coefficient 
Hausdorff 
Distance 
(mm) 
Average 
Surface 
Distance 
(mm) 
PTV 0.88 6.9 2.1 
Cord 0.94 8.3 0.3 
Heart 0.99 4.1 0.2 
Lung 0.99 6.3 0.3 
Bronchial Tree 0.96 1.4 0.1 
Trachea 0.97 1.4 0.2 
Vertebral Body 0.93 10.3 0.2 
Mean Value 0.95 5.5 0.4 
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4.4 Discussion: 
Deformable image registration will continue to be a key component in the 
implementation of adaptive radiotherapy with the ultimate goal of dose tracking and dose 
accumulation based on daily image feedback [126, 127, 146]. Verification of DIR 
accuracy is an important task in implementation of adaptive radiotherapy. We have 
presented a framework to test and evaluate the accuracy of DIR using known 
deformations which are clinically relevant that can be applied to any CT images. The 
accuracy of DIR was evaluated by comparing anatomical correspondence, physical 
characteristics of deformation field, and image characteristics. The relative merits of 
these methods in the final decision making on DIR accuracy for the anatomical sites 
studied is discussed below. 
Prostate: 
 Our results on prostate case indicate that the ICE was comparable to both algorithms. 
Also, the MSE values were very similar for both methods. However the B-Splines 
algorithm had significantly better anatomical correspondence for rectum and prostate 
than diffeomorphic demons algorithm. So considering the anatomical correspondence of 
the RT structures one can conclude that the B-Splines algorithm performed better. In this 
example the MSE and ICE evaluation parameters provide no criteria to determine which 
method performs better. 
Head and Neck:  
For the head and neck case, the ICE was much larger for the demons algorithm (6.5 mm) 
as compared to B-Splines (0.7 mm). The MSE was comparable for both algorithms. 
However, since the induced neck flexion was large, neither algorithm had a desired 
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anatomical correspondence for PTV and organs at risk that could make the result 
clinically acceptable. Similar to the prostate case, this example also indicates that 
considering only the ICE and MSE methods could lead to false positive conclusions.  
Lung:  
In the lung case B-Splines algorithm accurately estimated the deformations between 
images with variable contrast and was clearly superior in all the metrics that were 
evaluated. The demons algorithm had gross errors in areas of contrast differences 
between images. This was the only example where all metrics used for the DIR 
evaluation were in full agreement on the decision making of the DIR algorithm 
performance. 
Verification of absolute accuracy of DIR is a challenging problem as each of the methods 
studied has its own drawback. In the case of inverse consistency, a zero value for ICE is a 
necessary but not sufficient condition for an accurate algorithm as errors in one DVF may 
cancel out errors in the other to yield a net zero value during composition of two 
deformation maps.  
The determinant of the jacobian and the harmonic energy of the deformation field were 
used to classify the registration strategies based on invertibility and smoothness although 
they do not give information on the accuracy of DIR. However, one needs to confirm the 
non-negative value of jacobian of the deformation field to ensure that a given DVF is 
physically achievable by an organ [133, 134, 163]. The harmonic energy captures the 
non-linearity of the warp.  
The harmonic energy of B-Splines was consistently lower in all our examples and was 
generally small since it was physically constrained. The parameters that control it are the 
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maximum deviation the user allows (step length) during registration and the number of 
nodes specified in the command line. The harmonic energy of the diffeomorphic demons 
is controlled by the parameter “sigma” used to smooth the deformation field. Increasing 
sigma will reduce the harmonic energy but will come at the expense of reduced 
registration accuracy.  The harmonic energy from B-Splines registration was consistently 
lower on all our cases indicating that the deformation field from B-Splines was smoother. 
An abnormally large value of harmonic energy may indicate problems with DVF as was 
the case for demons algorithm during registration of images with variable contrast 
enhancement. However, there is nothing in the B-Splines algorithm that prevents 
negative jacobians which is physically unrealistic. Deformation fields from 
diffeomorphic demons on the other hand are guaranteed invertible and the jacobian is 
always non-negative.  
The image quality of a deformed image set and product of a DIR method is significant for 
the daily clinical routine when used to define OARs and target volumes. However, the 
use of the MSE as image quality metric is proven to be inadequate for drawing a useful 
and consistent conclusion. A small value of MSE indicates an overall good accuracy in 
the entire image voxel space but does not guarantee good accuracy of DVF inside the 
organs. Another option to address this issue is to make a selective MSE calculation 
within regions of interest (e.g. OARs) and investigating other image quality metrics. If 
unsure about the DIR image outcome, the images should be reviewed by a clinical expert.   
Ultimately the accuracy of DIR also needs to be validated with contour comparison 
methods as outlined in this study because the registration accuracy of RT structures and 
hence the partial volume doses received by these structures dictate the need for adaptive 
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radiotherapy. This evaluation proved to be the most consistent and reliable method in 
validating DIR accuracy in our study. 
DIR results in a daily clinical environment might be very variable and affected from 
various factors such as patient anatomy, image quality, and registration parameters of the 
particular algorithm. It should be well appreciated that the evaluation of a DIR algorithm 
for use in a clinical routine should be conducted in a long term study including a large 
number of clinical cases.  
4.5 Conclusion:  
We conclude that the proposed framework offers the application of known deformations 
on any patient or phantom image sets, that provide clinical medical physicist tools to test, 
understand and quantify limitations of each algorithm before implementing deformable 
image registration in the clinic. The evaluation based on anatomical correspondence, 
physical characteristics of deformation field and image characteristics can facilitate DIR 
verification with the ultimate goal of implementing adaptive radiotherapy. The suitability 
of application of a particular evaluation method is strongly dependent on the clinical 
deformation observed. 
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Chapter 5. Dose warping and experimental validation of accuracy of dose warping 
using deformable phantoms. 
5.1. Introduction: 
Deformable Image Registration (DIR) has gained wide spread acceptance with the 
availability of several commercial DIR platforms. To properly account for changes in 
patient anatomy over time, a cumulative dose distribution accounting for the 
deformations of organs over multiple data sets needs to be implemented. Dose warping or 
“deformable dose” defined as applying the deformation vector field (DVF) arising from 
DIR on the original dose distribution has the potential to accumulate doses to ultimately 
implement adaptive radiotherapy and has been the subject of great interest and 
controversy in the recent past.[19, 171, 172].  It is known that the accuracy of DIR 
algorithms can vary depending on the algorithm used and the suitability of application 
may be site specific[173, 174] potentially leading to errors in dose warping. However, 
verification of accuracy of dose warp remains a challenging problem as warping the dose 
with DVF may not represent the physical process of dose deposition in a deformed 
anatomy. 
There have been a number of studies done to validate the accuracy of dose warping using 
deformable phantoms and dosimeters. [103, 104, 127, 175-178]. Various  approaches 
include 1D (MOSFETs)[179], 2D (film) [176]and 3D (polymer gel)[104, 175] dose 
measurements in the deformed anatomy and also dose simulation in deformed anatomy 
using TPS dose have been done[179] and results compared to the warped dose from DIR.  
For example Yeo et al.,[104] evaluated the accuracy of dose warp for stereotactic 
irradiations for a range of algorithms available in the public domain using the DIRART 
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code [100] for 3 different deformation states of the polymer gel. Similarly, Similarly, Niu 
et al, [175] evaluated dose warp accuracy of the MORFEUS algorithm using a twelve 
field conformal plan while Juang et al, [180] used Presage-Def radio-chromic 3D 
dosimeter to verify a commercial B-spline algorithm.  
In this context the accuracy of “deformable dose” solution provided by commercial DIR 
algorithms is investigated in this chapter. The “deformable dose” in commercial DIR 
platforms is derived by applying the DVF from registration to TPS dose and providing 
the warped dose in the new anatomy. 
We illustrate the concept of “deformable dose” using two different methodologies as 
discussed below. 
 
Figure 5.1 a. Representation of the method to illustrate the concept of dose warping in 
reference image Ir.  
 
a 
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Figure 5.1 b Representation of the method to illustrate the concept of dose warping in the 
reference image Ir..  
a) Let Dr and Dk represent the “true” doses in un-deformed and deformed geometry 
respectively from TPS. If no dose warping is employed, {Dk-Dr} evaluated in 3D will 
indicate the magnitude of errors due to organ deformation. Applying the DVF to Dk will 
result in the warped dose Dk* in the original CT. If deformable image registration is 
perfect between images Ir and Ik, then all the voxels deformed in image Ik, will return to 
the original position when DVF is applied as shown in figure 5.1 b. for a individual 
marker Mk(Reg) = Mr.  The magnitude of difference between Dk the “true” dose received 
by the organ in the deformed geometry and Dk* the warped dose in the reference 
geometry indicates the agreement of dose warping in 3D. For a perfect dose deformation 
this difference {Dk-Dk*} should be zero. This is evaluated systematically by varying the 
amount of deformation using the deformable bladder phantom designed for this study and 
the schema is outlined in the flow chart in figure 5.1c below. The details of the phantom 
and the methods used are discussed in next section. 
5.1 b. Figure from G. Janssens et.al 
(2009) Reference 179 
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Fig 5.1c Flow chart illustrating the schema used to validate the dose warping in 
reference image geometry 
b) Alternately “dose deformation” can also be viewed from an inverse mapping.  Here the 
roles of source and target images are switched, as one is interested to know what is the 
magnitude of difference between warped dose on the deformed anatomy, when compared 
to the true dose received by the organ in deformed anatomy. In this scenario the 
commercial DIR workflows are propagating Dr* in the deformed geometry. This can be 
done in less than 2 minutes. However one must recognize Dr* and Dk are in fact two 
different doses. Dk refers to the “true” dose received by the organ in deformed geometry 
while Dr* is warped version of dose delivered in un-deformed state. If the warped dose 
Dr* is accurate, it is potentially very valuable for the radiation oncologist as the dose 
information (including DVH) can be made available quickly and it has potential 
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applications in dose accumulation[79, 81, 101]. However if it is not accurate, then it 
merely equivalent to “photo shopping” of dose. In general agreement of image 
registration does not guarantee accuracy of dose registration and radiation oncologists 
should not make clinical judgment based on the erroneous Dr* dose in the deformed 
anatomy. Deformable dose is useful to get different doses in the same coordinate system 
allowing “voxel” based comparisons to estimate changes in dose received by target and 
organs at risk due to organ deformation. Potentially if Dr* = Dk in a clinically relevant 
criteria, ( 3%, 3mm distance to target agreement)  then one can propagate the warped 
dose to estimate the dose received in deformed geometry without dose recalculation. 
However what is not known is, at what level of deformation, dose recalculation in 
deformed anatomy may be clinically necessary? This chapter seeks to address that by 
systematically evaluating the magnitude of {Dr
*
- Dk} induced by dose deformation  using 
the deformable bladder phantom using the schema outlined below in flow chart in figure 
5.1d below. 
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Fig 5.1d Flow chart illustrating the schema used to validate the dose warping in 
deformed image geometry. 
Although deformation has been studied in the context of dose warping, it is mostly used 
to describe arbitrary deformations for dose delivery verification.  The fundamental 
science of how to properly characterize different levels of deformation with applied force 
and the limits of applicability of dose warping to a dose painting scenario is not fully 
understood. A quantitative relationship between force and deformation may give insight 
into the deformation characteristics of other organs if their biomechanical properties are 
known and has the potential to create simulated deformations of various organs.  A force-
deformation relationship of organs has important applications in surgical simulations, 
optimizing surgical tool design and understanding tissue injury mechanism and damage 
thresholds[20]. 
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In a clinical context, an increasing number of patient treatment plans are generated with 
dose painting inside the target volume using Intensity Modulated Radiation Therapy 
(IMRT) and Volumetric Modulated Arc Therapy (VMAT) techniques for a wide variety 
of anatomical sites [181-193]. While dose warping may be applicable for a uniform 
homogeneous dose, its applicability in dose painting geometry has not been validated. 
The purpose of this study to a) verify the dose warping accuracy with invivo dosimetry 
using implanted MOSFETs in the deformed anatomy b) characterize the deformation of 
the organ with applied force, c) ascertain and establish a threshold limit for the dose warp 
accuracy from various commercial DIR algorithms studied, d) evaluate the efficacy of 
dose warping in dose painting scenarios and propose suitable validation methods.   
Part 1: 1D dose verification using MOSFETs in deformed anatomy. 
Methods and Materials: 
5.2 Deformable phantom for 1D dose warping verification in deformed anatomy: 
The deformable phantom was made from a solid water prototype (figure 5.2 a) with 
dimensions of 10.5 x 9 x 4.8 cm
3
 measuring 386cc in total volume, mimicking human 
“bladder-like” organ volume and geometry [194]. The solid water prototype was coated 
with mold release and a silicone rubber compound was poured around the organ. It was 
then placed in the vacuum chamber at a pressure of 25 inches of mercury for about 20 
hours. The mold was filled with Akton visco elastic polymer and the phantom was 
removed from the mold after hardening ( fig 5.2b). The Akton viscoelastic polymer 
(Action Products, Hagerstown, MD) used is tissue equivalent with relative electron 
density of 1.02 and physical density of 1.03g/cm
3
[195]. The tensile properties of the 
viscoelastic polymer used are described in more detail in the next section when 
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describing 3D dose verification. 5 parallel air canals that run along the organ were used 
for positioning MOSFET detectors at multiple locations.( Fig 5.3) For measuring the 
actual dose delivered in deformed geometry, metal oxide semiconductor field-effective 
transistor (MOSFET) dosimeter standard TN-502RD, (Best Medical, Canada) were used. 
Dose calculation was performed in un-deformed geometry with varying degree of dose 
gradients. The phantom was deformed using a compression plate and the resulting images 
before and after deformation along with the location of MOSFETs is shown in Fig 5.4. 
The maximum deformation of the organ along the axis of applied force was 15 mm. 
 
 
Figures 5.2 a, b showing the solid water prototype, and the viscoelastic polymer based 
deformable phantom respectively 
 
 
Fig 5.2. a Fig 5.2 b 
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Figure 5.3 Deformable bladder phantom with 5 parallel air canals for 1D dose 
verification using MOSFETs 
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i  
Figure 5.4 CT images of bladder phantom in undeformed and deformed positions along 
with locations of 5 MOSFETS 
5.3 Deformable image registration algorithms studied for 1D dose warping: 
In this work we assess the suitability of DIR based dose warping ( using 1D point dose 
measurement with MOSFETs) for the commercially available DIR algorithm namely the 
free form intensity based deformation from MIM 5.6 (MIM Software, OH) and also the 
B-spline algorithm found in the open source Slicer-RT platform[196] . MIM software 
(MIM) uses a free form fully automatic intensity based deformation with a multi-
resolution approach[110] and the details of the B-spline algorithm using Slicer-RT were 
discussed in Chapter 4. 
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5.4 Beam geometries studied for 1D dose warping: 
Five different beam geometries were studied to evaluate the efficacy of dose warping 
using MOSFETs. They are 
1) A uniform 10 x 10 cm2 field 
2) 60 degree Enhanced Dynamic Wedge (EDW 60) with a collimator rotation of 45 
degrees.  
3) 60 degree Enhanced Dynamic Wedge (EDW 60) with collimator angle of 0 
degrees where the induced dose gradient is in an opposite direction to previous 
example 2. This results in a dose gradient across organ as shown in figure 5.5 
below 
4) A sweeping MLC gap across the organ with a gap width of 0.5 cm 
5) A sweeping MLC gap across the organ with a gap width of 1 cm. 
The MOSFETS were moved 3 times along each air canal position and thus a total of 15 
MOSFET measurements were performed for each of the five beam geometries studied. 
 
Figure 5.5 Sagittal view of 60 degree Enhanced Dynamic Wedge doses with original dose 
on original CT (left), and deformed old dose on deformed CT (right).  
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5.5. Dose warping evaluation Scheme for MOSFETs. 
The dose warping accuracy using MOSFETS was evaluated using the following 
methodology similar to the work in Ref [179]. Accuracy of the dose warping was 
assessed by using two comparison techniques. The first validation was made using 
the simulation of dose distribution planning where the warped dose from DIR was 
compared to the directly calculated dose from Eclipse TPS in the deformed geometry. 
The second validation was made with the dose directly measured by the MOSFET 
detectors in the deformed geometry and compared to the warped dose from DIR 
algorithms. Let D(ri) denote the dose received by each MOSFET at position ri in the 
undeformed state. Under the influence of applied deformation the dose received by each 
MOSFET is D(rk)    The percentage error in dose warping accuracy for each MOSFET at 
each beam geometry studied was evaluated using the formulae 
Dose warp error using MOSFETS = {D
DIR
(rk) - D(MOSFETk)/ D(MOSFETk) 
where D
DIR
(rk) refers to the warped dose of MOSFET in the deformed location rk. 
Similarly the dose warp error using Eclipse TPS was evaluated using the formulae 
Dose warp error using TPS = {D
DIR
(rk) - D(TPSk)}/ D(TPSk) 
Where D(TPSk) refers to the dose directly recalculated at each MOSFET location rk  in 
the treatment planning system in the deformed geometry 
5.6.Results of deformable dose evaluation using MOSFETs 
Tables 5.1 to 5.5 detail the 15 individual MOSFET raw data readings and the TPS dose at 
each MOSFET location for both undeformed and deformed geometry when compared to 
the warped dose from DIR algorithms for each of the 5 beam geometries studied. The 
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results of 15 MOSFET measurements were averaged and are summarized in Figures 5.6 
for TPS dose simulation and figure 5.7 for MOSFET measurement. 
 
 
 
Figure 5.6 illustrating the agreement between warped dose from DIR algorithms and 
dose directly recalculated in the TPS in the deformed geometry for each of the 5 beam 
geometries given in section C. The data shown represents the average TPS dose at the 15 
MOSFET locations in the deformed geometry. 
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Figure 5.7 illustrating the agreement between warped dose from DIR algorithms and 
dose directly measured by MOSFETs in the deformed geometry for each of the 5 beam 
geometries given in section C. The data shown represents the average of the 15 MOSFET 
readings for each beam geometry. 
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-
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1 37.8 36.8 2.65 38 37.4 37.8 -0.53 36.8 
-
1.60 38.4 1.05 2.67 37.7 
-
0.79 0.80 
2 41.4 40.9 1.21 42.1 41.2 41.4 -1.66 40.9 
-
0.73 43 2.14 4.37 42.5 0.95 3.16 
3 50.7 50.1 1.18 51.2 50.5 50.7 -0.98 50.1 
-
0.79 51.2 0.00 1.39 51.7 0.98 2.38 
4 50.5 50 0.99 50 49.8 50.5 1.00 50 0.40 50.6 1.20 1.61 50.4 0.80 1.20 
5 57.6 56.8 1.39 56.8 54.7 57.6 1.41 56.8 3.84 60.8 7.04 11.2 55.5 
-
2.29 1.46 
6 43.2 42.6 1.39 43.6 43.5 43.2 -0.92 42.6 
-
2.07 44.7 2.52 2.76 42.7 
-
2.06 -1.84 
7 47.9 47.2 1.46 48.7 49.2 47.9 -1.64 47.2 
-
4.07 51.5 5.75 4.67 48.8 0.21 -0.81 
8 56.3 56.1 0.36 57.1 56.3 56.3 -1.40 56.1 
-
0.36 58.2 1.93 3.37 58.3 2.10 3.55 
9 63.8 61.7 3.29 64 64.5 63.8 -0.31 61.7 
-
4.34 66 3.13 2.33 64.04 0.06 -0.71 
10 68.1 66.1 2.94 66.2 64.8 68.1 2.87 66.1 2.01 66.3 0.15 2.31 66.1 
-
0.15 2.01 
11   35.5   36.5 35.8     35.5 
-
0.84 36.7 0.55 2.51 36.7 0.55 2.51 
12   35.6   36.8 35.9     35.6 
-
0.84 36.7 
-
0.27 2.23 36.4 
-
1.09 1.39 
13   44.7   46.8 45.7     44.7 
-
2.19 47.1 0.64 3.06 47.3 1.07 3.50 
14   46.2   47.3 47.7     46.2 
-
3.14 47.3 0.00 
-
0.84 46.2 
-
2.33 -3.14 
15   51.3   53.1 51.7     51.3 
-
0.77 56 5.46 8.32 52.5 
-
1.13 1.55 
  
                
AVG Percent Change 
(%) 1.68       -0.22   
-
1.03   2.09 3.46   
-
0.21 1.13 
  
            Table 5.2. MOSFET measurements in deformed 
anatomy for EDW 60 with 45 deg collimator angle  
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10 x 10 EDW60  
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1 39.3 38.9 1.02 39.9 38.3 39.3 
-
1.50 38.9 1.57 38.4 
-
3.76 0.26 40.7 2.01 6.27 
2 44.3 43.9 0.90 45.1 42.8 44.3 
-
1.77 43.9 2.57 43.7 
-
3.10 2.10 46.2 2.44 7.94 
3 51.8 50.9 1.74 52.8 51.2 51.8 
-
1.89 50.9 
-
0.59 51.7 
-
2.08 0.98 53.9 2.08 5.27 
4 60.2 58.2 3.32 60.2 59.7 60.2 0.00 58.2 
-
2.51 60.2 0.00 0.84 61.3 1.83 2.68 
5 66.8 65 2.69 65.6 65.1 66.8 1.83 65 
-
0.15 66.7 1.68 2.46 64.2 
-
2.13 
-
1.38 
6 38.8 38.4 1.03 40 39.9 38.8 
-
3.00 38.4 
-
3.76 38.1 
-
4.75 
-
4.51 40 0.00 0.25 
7 43.8 43.1 1.60 45.3 44.1 43.8 
-
3.31 43.1 
-
2.27 44.2 
-
2.43 0.23 46.2 1.99 4.76 
8 52.4 51.4 1.91 54.1 53.6 52.4 
-
3.14 51.4 
-
4.10 52.4 
-
3.14 
-
2.24 55.5 2.59 3.54 
9 60.8 59.3 2.47 61.1 59.1 60.8 
-
0.49 59.3 0.34 60.5 
-
0.98 2.37 61.8 1.15 4.57 
10 67.9 65.8 3.09 66.3 65.4 67.9 2.41 65.8 0.61 67.1 1.21 2.60 66.5 0.30 1.68 
11 39.1 38.1 2.56 40.2 39 39.1 
-
2.74 38.1 
-
2.31 38.6 
-
3.98 
-
1.03 40.9 1.74 4.87 
12 43.8 42.5 2.97 44.8 42.8 43.8 
-
2.23 42.5 
-
0.70 43.9 
-
2.01 2.57 44.3 
-
1.12 3.50 
13 51.3 49.4 3.70 53 50.8 51.3 
-
3.21 49.4 
-
2.76 51.3 
-
3.21 0.98 54.1 2.08 6.50 
14 60.6 59.7 1.49 60.8 60.2 60.6 
-
0.33 59.7 
-
0.83 60.1 
-
1.15 
-
0.17 60 
-
1.32 
-
0.33 
15 68.6 67.1 2.19 66.9 65.5 68.6 2.54 67.1 2.44 66.8 
-
0.15 1.98 66.2 
-
1.05 1.07 
  
               AVG Percent Change 
(%) 2.18       
-
1.12   
-
0.83   
-
1.86 0.63   0.84 3.41 
  
Table 5.3. MOSFET measurements in 
deformed anatomy for EDW 60 field 
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1 42.9 40.9 4.66 41.8 40.6 42.9 2.63 40.9 0.74 42.9 2.63 5.67 41.1 
-
1.67 1.23 
2 42.9 40.5 5.59 42.4 41.1 42.9 1.18 40.5 
-
1.46 42.3 
-
0.24 2.92 42.4 0.00 3.16 
3 42.7 43.1 
-
0.94 43 41.4 42.7 -0.70 43.1 4.11 42.7 
-
0.70 3.14 43.6 1.40 5.31 
4 43.7 42 3.89 43.8 42.5 43.7 -0.23 42 
-
1.18 43.7 
-
0.23 2.82 44.4 1.37 4.47 
5 42.2 41 2.84 41.8 40.1 42.2 0.96 41 2.24 41.8 0.00 4.24 41.9 0.24 4.49 
6 42.8 40.4 5.61 41.5 39.5 42.8 3.13 40.4 2.28 43 3.61 8.86 40.5 
-
2.41 2.53 
7 42.5 39.9 6.12 42.1 41.2 42.5 0.95 39.9 
-
3.16 42.9 1.90 4.13 42.1 0.00 2.18 
8 43.3 41.3 4.62 43.6 41.8 43.3 -0.69 41.3 
-
1.20 43.5 
-
0.23 4.07 44.4 1.83 6.22 
9 43.4 40 7.83 43.5 42.8 43.4 -0.23 40 
-
6.54 43.7 0.46 2.10 43.9 0.92 2.57 
10 42.2 39.7 5.92 41.8 39.5 42.2 0.96 39.7 0.51 42.1 0.72 6.58 42.4 1.44 7.34 
11 43.3 41.4 4.39 42.5 41.9 43.3 1.88 41.4 
-
1.19 42.9 0.94 2.39 41.4 
-
2.59 -1.19 
12 43.3 41.6 3.93 43.3 41.5 43.3 0.00 41.6 0.24 43.2 
-
0.23 4.10 42.3 
-
2.31 1.93 
13 43.1 41.7 3.25 43.5 41 43.1 -0.92 41.7 1.71 42.9 
-
1.38 4.63 44.3 1.84 8.05 
14 44.3 42.7 3.61 43.3 42.4 44.3 2.31 42.7 0.71 44.2 2.08 4.25 43.9 1.39 3.54 
15 42.9 41.1 4.20 42.6 41.1 42.9 0.70 41.1 0.00 42.2 
-
0.94 2.68 42.9 0.70 4.38 
  
               AVG Percent Change 
(%) 4.37       0.80   
-
0.15   0.56 4.17   0.14 3.75 
  
Table 5.4. MOSFET measurements in 
deformed anatomy for MLC Gap width of 
0.5 cm  
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1 35.8 35.1 1.96 35 33.7 35.8 2.29 35.1 4.15 35.8 2.29 6.23 34.4 
-
1.71 2.08 
2 35.8 35 2.23 35.4 33.5 35.8 1.13 35 4.48 35.3 
-
0.28 5.37 35.2 
-
0.56 5.07 
3 35.6 35.4 0.56 35.9 34.1 35.6 
-
0.84 35.4 3.81 35.7 
-
0.56 4.69 36.2 0.84 6.16 
4 36.5 35.2 3.56 36.6 35.5 36.5 
-
0.27 35.2 
-
0.85 36.5 
-
0.27 2.82 36.8 0.55 3.66 
5 35.2 33.9 3.69 35 33.9 35.2 0.57 33.9 0.00 34.9 
-
0.29 2.95 34.8 
-
0.57 2.65 
6 35.7 34.3 3.92 34.7 33.4 35.7 2.88 34.3 2.69 35.8 3.17 7.19 33.8 
-
2.59 1.20 
7 35.5 34.8 1.97 35.2 34.8 35.5 0.85 34.8 0.00 36.2 2.84 4.02 35.1 
-
0.28 0.86 
8 36.2 35.4 2.21 36.4 35.1 36.2 
-
0.55 35.4 0.85 36.4 0.00 3.70 37.1 1.92 5.70 
9 36.3 35.2 3.03 36.3 34.9 36.3 0.00 35.2 0.86 36.6 0.83 4.87 36.7 1.10 5.16 
10 35.3 33.9 3.97 34.9 34.4 35.3 1.15 33.9 
-
1.45 35.4 1.43 2.91 35.4 1.43 2.91 
11 36.2 35.2 2.76 35.4 34.2 36.2 2.6% 35.2 2.92 35.8 1.13 4.68 34.5 
-
2.54 0.88 
12 36 35 2.78 35.9 35.1 36 0.28 35 
-
0.28 35.9 0.00 2.28 34.9 
-
2.79 -0.57 
13 35.9 34.5 3.90 36.3 34.6 35.9 
-
1.10 34.5 
-
0.29 35.8 
-
1.38 3.47 36.9 1.65 6.65 
14 36.9 35.8 2.98 37.1 35.2 36.9 
-
0.54 35.8 1.70 36.8 
-
0.81 4.55 36.5 
-
1.62 3.69 
15 35.8 34.6 3.35 35.6 34.5 35.8 0.56 34.6 0.29 35.2 
-
1.12 2.03 35.9 0.84 4.06 
  
               AVG Percent Change 
(%) 2.86       0.58   1.26   0.47 4.12   
-
0.29 3.34 
 
5.7. Conclusion and limitations of MOSFET measurements 
 
The dose warping accuracy studied for the applied deformation (15 mm maximum 
deformation) yielded acceptable results (< 5% overall disagreement) for all the beam 
geometries studied. The dose warping accuracy was better when dose simulation from 
TPS was used as the ground truth. This is due to the inherent uncertainties in MOSFET 
Table 5.5. MOSFET measurements in 
deformed anatomy for MLC Gap width of 
1cm 
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measurement in highly modulated geometries like EDW 60 and MLC gap widths studied. 
It has been shown that the inherent uncertainty in MOSFET measurement in highly 
modulated fields like IMRT is 4.6%[197]. The dose warping accuracy studies using 
MOSFETs have two major drawbacks. 1) Although dose warping accuracy studies using 
1D point dose measurement using arbitrary deformations give some degree of agreement 
and validity to DIR based dose warping, they cannot be extrapolated to agreement in 
other locations within the organ. To meaningfully compare dose warp accuracy, the entire 
3D dose matrix has to be evaluated. 
2) Dose warp accuracy evaluations using arbitrary deformations as done by vast majority 
of research groups do not parameterize the deformation of the organ with its causative 
physical force. To gain scientific insight to the actual deformation of organs, deformation 
must be linked to the physical force causing the observed deformation as described in 
Chapter 1. The fundamental relationship between force and deformation of organs has 
many scientific applications and are discussed in the next section. 
To overcome these drawbacks we designed a new deformable phantom and evaluated the 
dose warp accuracy (3D dose) using a novel methodology which is described in the next 
section 
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PART 2: 3D Dose verification 
 
Applicability and Limits of Dose Warping - Are There Islands of Deformation that 
Fail to Depict Dose Painting? 
5.8. Deformable bladder phantom and deformation studied for 3D dose verification: 
 
The deformable phantom for 3D dose verification was made from the same solid water 
prototype described before, with dimensions of 10.5 x 9 x 4.8 cm
3
 measuring 386cc in 
total volume, mimicking human “bladder-like” organ volume and geometry [194]. The 
solid water prototype was coated with mold release and a silicone rubber compound was 
poured around the organ. It was then placed in the vacuum chamber at a pressure of 25 
inches of mercury for about 20 hours. The mold was filled with Akton visco elastic 
polymer and the phantom was removed from the mold after hardening. The Akton 
viscoelastic polymer (Action Products, Hagerstown, MD) used is tissue equivalent with 
relative electron density of 1.02 and physical density of 1.03g/cm
3
[195]. It has peak 
tensile strength of 157 kPa and Young’s modulus of 17.9 kPa[198]. The mechanical and 
tensile properties of the phantom are comparable to human bladder with Young’s 
modulus of 16 kPa[199, 200] , density of 1.04 g/cm
3
 [201], and peak tensile strength of 
270±140 kPa[202] . A coating of blue plastidip, an air-dry synthetic rubber which resists 
moisture and absorption, was applied on the phantom. The bladder phantom was placed 
between the apparatus for measuring force-deformation properties (Fig. 5.8). The 
apparatus made of acrylic has a mechanical piston at one end, and is fitted with a 
customized miniature load cell with National Institute of Standards and Technology 
(NIST) traceable calibration. The load cell accurately measured the applied force induced 
by the piston on the phantom with excellent reproducibility and linearity[203]. The load 
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cell was connected to a digital process meter and controller which displays the applied 
force on the deformable phantom. A precision weight was used to calibrate the accuracy 
of the load cell and readout.  The applied force on the phantom was varied incrementally 
from 10 N to 70N along the longitudinal axis (+z axis) of the phantom, and although the 
maximum deformation (compression) is along ±z axis, there is expansion and 
compression in other axis and the deformation observed on the organ is three 
dimensional. Deformation is quantified both in terms of maximum 1D deformation 
observed along the direction of applied force and also the 3D deformation quantified by 
the 95 percentile Hausdorff distance (95% HD) [168]. Hausdorff distance measures the 
maximum of the closest distance between two volumes where the closest distance is 
computed for each vertex of the two volumes. The 95% HD ensures that the outliers are 
rejected. To calculate the 95% HD, the external body contour of the deformable phantom 
in each deformation state was contoured and compared against the surface contour in 
undeformed state using Slicer RT[196]. 
 
Fig 5.8 Apparatus for investigating force-deformation properties 
5.9 Deformable image registration algorithms studied for 3D dose warping 
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 In this work we assess the suitability of DIR based dose warping for the various 
commercially available DIR algorithms namely the free form intensity based deformation 
from MIM 6.0.1 (MIM Software, OH) and both the single pass and multi-pass 
deformation from Velocity AI 3.0 (Velocity Medical Solutions, GA). MIM software 
(MIM) uses a free form fully automatic intensity based deformation with a multi-
resolution approach[110]. The details of the algorithm parameters, including smoothness 
criteria, are proprietary and are not user-defined. Velocity AI uses a modified B-spline 
algorithm [87, 89] combined with Mattes mutual information metric[160]. Similar to 
MIM, the algorithm parameters are not user-defined but are instead inherent to the 
software. The number of control points in Velocity AI can be varied depending on the 
choice of multi-pass or single pass registration modes in the software. In the single pass 
mode, (VEL-SD) the finest grid resolution is applied while in the multi-pass mode(VEL-
MD) the grid resolution spacing started at the coarse setting and gradually went down to 
the finest in multiple steps which potentially helps to make the convergence of the 
optimizer in a shorter time. 
5.10. Dose warping validation for Dose painting: 
Dose warping accuracy in deformed anatomy: 
The accuracy of dose warp in deformed image is validated in this study using the 
methodology outlined in the flow chart. (Figure 5.9).The deformable phantom was placed 
between the compression plate and a CT scan was obtained using a GE Light Speed CT 
scanner in the undeformed geometry. Using the same imaging acquisition mode, the 
phantom was successively scanned at various deformed states. The images were 
processed and cropped to remove the acrylic plate holding the phantom. Both the 
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commercial DIR platforms have dose deformation work flow navigators which warp the 
original treatment planning system (TPS) dose in an undeformed state with DVF from 
DIR to display a warped dose in the deformed or new organ geometry. The warped doses 
were then exported from the respective DIR platform as DICOM RT Dose files and 
analyzed for dose warp accuracy.  Next, this was compared to the corresponding dose 
recalculated in TPS. The accuracy of dose warp was evaluated using two different 
metrics. First, 3D γ analysis[204, 205]  which is an extension of the original 2D planar 
gamma evaluation[206] by considering DTA agreement in 3D was performed by 
comparing the warped doses from each of the DIR algorithms with dose from TPS using 
the Slicer RT[196] routines. The passing criteria for all the doses was calculated for those 
voxels receiving greater than 10% of maximum dose ( 10 % threshold) as discussed in 
AAPM Task Group Report 119 [207]. Next, the volumes of high dose paint from various 
DIR algorithms is compared to the volume of high dose gradient from TPS to evaluate 
the efficacy of dose warping in a dose painting scenario. As discussed before, in a dose 
painting scenario the volume of high dose received by the target is of critical importance 
as one attempts to put localized high dose volume to the target. Hence, the ratio of high 
dose volumes between true dose received by the target ( as calculated from TPS)  and 
warped dose from DIR algorithms is more likely to indicate the accuracy of dose warping 
in a dose painting scenario. This is because, the usual 3mm distance to target agreement 
(DTA) used in γ3D analysis may not accurately depict the accuracy of warping due to 
averaging of low and high dose voxels in the area of interest. Further the Dice similarity 
coefficient (DSC) and 95% HD was evaluated for the high dose volume surfaces to 
indicate the spatial agreement of high dose volumes. 
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Figure 5.9 Flowchart illustrating the validation of dose warp accuracy in deformed 
anatomy 
Dose warping accuracy in reference anatomy: 
The accuracy of dose warp in reference image is validated in this study using the 
methodology outlined in the flow chart. (Figure 5.12). In contrast to the previous work 
flow the roles of source and target image are switched here. If DIR and consequently 
dose warping was perfect, then the magnitude of difference between {Dk – Dk*} would 
be zero. As before 3D gamma analysis was used to quantitatively evaluate the agreement 
of 3D doses for each of the beam geometries studied. 
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Figure 5.10 Flowchart illustrating the validation of dose warp accuracy in reference 
image. 
5.11 Deformation states and dose paint spatial location beam geometries: 
In this study we systematically deform the organ in successive increments by changing 
the applied force.  
In this work we introduced islands of high doses (in addition to a reference 10 x 10 cm
2 
 
field) at different spatial locations of the organ viz. a) along the edges and b) center of the 
organ to evaluate the accuracy of dose warp. It should be noted that often in a clinical 
context significant deformation occurs in the area of high dose gradients similar to the 
ones encountered in the prostate/rectal interface, parotid/tumor etc. Hence in this study 
we introduced islands of high doses where there is significant deformation as in the edges 
of the organ and moved the area of high dose paint from edges to the center of organ to 
study if the DIR based dose warping has any impact on the spatial location of dose paint 
for each of the deformation states. This was compared to a reference 10 x 10 cm
2 
uniform 
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dose. The dose painting treatment plans were generated using Eclipse TPS by starting 
with a standard 10 x 10 cm
2 
field and then adding six sub fields with independent jaws of 
varying field sizes to create a localized hot spot. AAA algorithm with 1mmm grid 
resolution was used on all the treatment plans. All plans were generated with a fixed 
gantry angle of 0
 
degrees (AP) 6MV photons beams and a prescription dose of 5Gy.  
 
The beam parameters for the respective dose paint geometries are shown in Tables 5.6 
and 5.7.  
Table 5.6 Beam parameters for dose painting at superior and inferior edges of organ  
Beam 
number 
X1 jaw (cm) X2 jaw (cm) Y1 jaw (cm) Y2 jaw (cm) Monitor 
units 
1 5 5 5 5 430 
1.1 5 5 5 -3.0 30 
1.2 5 5 5 -2.7 30 
1.3 5 5 5 -2.4 30 
1.4 5 5 -3.0 5 30 
1.5 5 5 -2.7 5 30 
1.6 5 5 -2.4 5 30 
 
Table 5.7 Beam parameters for dose painting at center of organ: 
Beam 
number 
X1 jaw (cm) X2 jaw (cm) Y1 jaw (cm) Y2 jaw (cm) Monitor 
units 
1 5 5 5 5 430 
  143 
1.1 5 5 0.3 5 30 
1.2 5 5 0.6 5 30 
1.3 5 5 0.9 5 30 
1.4 5 5 5.0 0.3 30 
1.5 5 5 5.0 0.6 30 
1.6 5 5 5.0 0.9 30 
 
The resulting dose paint volumes are given in Figures 5.11 a b with Figure  5.11 c, 
showing a uniform 10 x 10 cm
2 
field. 
. 
 
Figures 5.11, a, b, c above representing sagittal view of the phantom in undeformed state 
showing dose gradient at the edges, center and a uniform 10 x 10 cm field respectively. 
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5.12 Results of 3D dose warping 
5.12.1 Response of applied force vs. deformation: 
The applied force on the deformable phantom was incrementally varied from 10N to 70N 
along the +z axis, deforming the phantom as shown in Fig. 5.12 a. The Dice similarity 
coefficient (DSC) (defined in chapter 4) between the un-deformed organ surface and each 
deformed organ surface as a function of applied force is shown in Fig 5.12 b. This gives 
the extent of shape changes in volume of organ. As seen in 5.14 b the DSC is ≥ 0.9 
between 10N to 30N applied force indicating that external shape changes of organ were 
minimal up to 30N. This mass and density preserving deformation ranged from 3mm to 
34mm along ±z axis, representing a bilateral compression of equal displacement from 
both sides. The deformation showed a linear response to the applied force with R
2
= 0.99. 
The 3D deformation as quantified by the 95% HD varied from 2mm to 16 mm with R
2
= 
0.96. This is compared to the predicted deformation along the superior-inferior direction 
(±z) using a simple linear elastic model for human bladder that follows Hooke’s law, z =  
  
 
 = 
 
 
 
 
 
  where E= Young’s modulus (16 Kpa) and 
 
 
(force per unit area) is the applied 
load. (Fig. 5.12c). 
 
 
Fig. 5.12 a. Various deformation states of the phantom in response to applied force. 
  145 
 
Figure 5.12 b. Dice similarity coefficient of external surfaces between un-deformed 
organ and each deformed state of organ as a function of applied force  
 
 
 
Fig. 5.12 c. Relationship between applied force and deformation observed in the 
deformable phantom and predicted in human bladder. 
5.12.2 Dose warp accuracy with 3D γ3%3mm statistics: 
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Figs. 5.12 d-f, provide 3D γ3%3mm pass rates at each deformation state for dose painting at 
the edges, center, and a uniform 10 x 10 cm
2 
field respectively. Beyond a threshold 
applied force of 30N, γ3%3mm pass rates fall below 90% for all commercial DIR 
algorithms, corresponding to 13 mm maximum organ deformation. For dose painting at 
the center, the dose warp accuracy yielded better results in the 10N to 40N applied 
deformation for the B-spline algorithm used by Velocity AI. The volume of high dose at 
the center was clearly misaligned in MIM beyond 30N as shown in Fig. 5.12 g. Using the 
γ3%3mm metric, the magnitude of deformation was the sole predictor of the dose warp 
accuracy. 
 
 
Fig. 5.12d. 3D γ3%3mm pass rates for dose painting at the edges of organ  
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Fig. 5.12e. 3D γ3%3mm pass rates for dose painting at the center of organ 
 
 
Fig. 5.12f. 3D γ3%3mm pass rates for a uniform 10 x 10 cm
2
 field  
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Fig. 5.12g Sagittal view (y-z plane) of bladder phantom displaying calculated dose 
(from TPS) received by organ at 40N deformation and corresponding warped doses 
from DIR for center dose painting plan.  
5.12.3 Dose warp accuracy using volumes of high dose comparison: 
Figs. 5.12 h-j displays the conformity index (defined as the ratio of volume of high dose 
from DIR to the corresponding volume from TPS) at each deformation state as a function 
of applied force. A conformity index of 1.0 would indicate perfect agreement between the 
dose volumes. For dose painting scenarios, none of the DIR algorithms studied were 
shown to accurately represent the volume of dose received by the organ, even at low 
deformation levels (Figs. 5.12 h,i).  
For a uniform homogenous dose, the conformity index is within ± 2% for applied forces 
of up to 30N (Fig. 5.12j), indicating results in line with the γ3%3mm pass rates.  
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Fig. 5.12h. Conformity index at 5Gy for the dose painting at the edges of the organ  
 
Fig. 5.12i. Conformity index at 5.5 Gy for dose painting at center 
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Fig. 5.12j. Conformity index at 5Gy for a uniform 10 x 10 cm
2 
field 
 
5.12.4 Dose warp accuracy comparing Dice similarity coefficient between high dose 
volumes: 
Figs. 5.12 k-m displays the Dice similarity coefficient (DSC) at each deformation state as 
a function of applied force for the high dose volumes. A DSC of 1.0 would indicate 
perfect agreement between the overlap of dose volumes. For dose painting scenarios, 
none of the DIR algorithms studied were shown to accurately represent the dose volume 
overlap at 5Gy and 5.5 Gy doses, even at low deformation levels (Figs. 5.12k,l).  For a 
uniform homogenous dose, ( 10 x 10 cm
2
field )  the DSC is within ± 6% for applied 
forces of up to 30N (Fig. 5.12m), indicating results in line with the γ3%3mm pass rates.  
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Fig. 5.12k. DSC at 5Gy for the dose painting at the edges of the organ  
 
 
Fig. 5.12l. DSC at 5.5 Gy for dose painting at center 
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Fig. 5.12m. DSC at 5Gy for a uniform 10 x 10 cm
2 
field 
 
5.12.5 Dose warp accuracy comparing 95% HD between high dose volumes: 
Figs. 5.12 n-p displays the 95% HD (mm) compared between dose volumes from DIR 
algorithms and TPS dose at each deformation state as a function of applied force. This 
indicates the spatial distance of the high dose volume from DIR algorithms away from 
true dose received by the organ (TPS). 
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0.8 
0.9 
1 
1.1 
0 10 20 30 40 50 60 70 80 
D
IC
E 
R
at
io
 
Force (N) 
DICE at 5Gy for Uniform 10x10 cm2 Field 
MIM 
VELMD 
VELSD 
  153 
 
Fig. 5.12n. 95%HD between 5Gy dose volumes for the dose painting at the edges of 
the organ  
 
 
Fig. 5.12o. 95% HD between 5.5 Gy dose volumes for dose painting at center 
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Fig. 5.12p. 95%HD between 5Gy dose volumes for a uniform 10 x 10 cm
2 
field 
 
5.13 Dose warp accuracy in reference geometry with 3D γ3%3mm statistics: 
Figure 5.13a   below gives the 3D gamma pass rate between un-deformed organ and each 
deformed state of the organ as a function of applied force for each beam geometry 
studied. This figure illustrates what the dose errors in a deforming organ would result if 
dose warping was not employed. As shown in figure, the maximum disagreement and 
necessity for dose warping is warranted for dose painting at edges of the organ where 
there is maximum dose gradient and deformation. 
Figs. 5.13 b-d, provide 3D γ3%3mm pass rates when comparing the warped dose in 
reference geometry to the true dose in deformed geometry each deformation state for 
dose painting at the edges, center, and a uniform 10 x 10 cm
2 
field respectively. 
0 
2 
4 
6 
8 
10 
12 
14 
16 
0 10 20 30 40 50 60 70 80 
9
5
%
 H
D
 D
is
ta
n
ce
(m
m
) 
Force (N) 
95% HD between 5Gy dose volumes 
for Uniform 10x10 cm2 Field  
MIM 
VELMD 
VELSD 
  155 
As it can be seen, none of the DIR algorithms performed well in showing an 
improvement over baseline disagreement induced due to organ deformation. 
 
Fig. 5.13a. 3D γ3%3mm pass rates between un-deformed organ and each of the 
deformed state of the organ as a function of applied force for all the beam 
geometries 
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Fig. 5.13 b. 3D γ3%3mm pass rates between warped dose in reference geometry for 
dose painting at the edges  of organ when compared to the true dose received by the 
organ in deformed geometry 
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Fig. 5.13 c. 3D γ3%3mm pass rates between warped dose in reference geometry for 
dose painting at the center  of organ when compared to the true dose received by the 
organ in deformed geometry 
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Fig. 5.13 d. 3D γ3%3mm pass rates between warped dose in reference geometry for 
uniform 10 x 10 cm
2 
field when compared to the true dose received by the organ in 
deformed geometry 
5.14 Discussion. 
We have established a threshold limit of 13mm maximum 1D and 6.8mm 3D 
deformation beyond which dose warp accuracy fails for both uniform homogeneous dose 
and dose painting geometries. The linear response observed in this study between applied 
force and deformation is typical of the biomechanical properties of human bladder in 
contrast to other pelvic organs like rectum, vaginal tissue and liver which show increased 
resistance to deformation with applied force [208, 209] . 
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Although 3D gamma (γ3%3mm)  pass rates ( in the deformed geometry) are excellent up to 
30N for the dose painting geometries studied, the conformity index(average  dose volume 
30 cc or greater) differs by 20% or larger even for the lowest deformation studied. This is 
in contrast to a uniform 10 x 10 cm
2
 field where the γ3%3mm pass rates and conformity 
index studied at 5 Gy dose level agree with one another. This is also consistent with Dice 
similarity coefficient comparison (DSC) between high dose volumes from dose painting.  
Even at the lowest 10N applied force, the DSC between 5Gy dose volumes is only 0.82 
for dose painting at the edges of the organ.  Thus, although a uniform homogeneous dose 
may yield acceptable results in terms of both 3D gamma pass rates and volume of dose 
received by the organ, this does not apply for dose painting. As a result, while employing 
dose warping for dose painting scenarios like those encountered in Stereotactic Body 
Radiation Therapy (SBRT) and other hypofractionated treatments with adaptive 
radiotherapy potential, the volume of dose received by the target from dose warping 
needs to be evaluated because dose painting is done under the assumption that high dose 
gradients are localized to the target.  
Further when the warped dose in reference geometry was compared to the true dose 
received by the organ in deformed geometry (Section 5.13), all the DIR algorithms 
performed poorly. There was no significant improvement over the baseline disagreement 
except at greater than 40N induced deformation, for dose painting at the edges of organ. 
In many instances it was found that dose warping induced more errors than the baseline 
disagreement. 
It should be noted that although boundary matching appears perfect even at 70 N (34mm 
deformation) between images from all the DIR algorithms, this does not guarantee the 
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accuracy of dose warping. Dose warp accuracy is a function of registration accuracy and 
dose gradient at a particular voxel. As a result, a small registration error at a high dose 
gradient will likely have a greater impact on the overall dose warp accuracy as compared 
to a larger registration error at a low dose gradient[127]. This effect is shown in the 
gamma wash color map at 40 N (18 mm deformation) for dose painting at the edges of 
organ. The maximum disagreement as indicated by the red color wash (γ3%3mm >1) occurs 
in the area of high dose gradient and large deformation for all the DIR algorithms studied 
(Fig.5.14 a-c). Although beyond the scope of this study, the high dose islands described 
at the edges of the bladder phantom are routinely encountered in clinical practice in 
intensity modulated treatment of prostate cancer. Fig. 5.13d shows a typical patient 
anatomy with overlap of prostate with bladder and rectal volumes along with the 
prescribed target dose (75.6 Gy) at the edges of bladder. The deformation of organs and 
the resultant dose warp accuracy for dose painting as described in this study will have a 
significant impact on the partial dose volumes received by the organs at risk. 
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Figs. 5.14 a, b, c showing sagittal view (y-z plane) of gamma volume at 40N deformation 
for dose painting at the superior and inferior edges of the organ for MIM, VELMD and 
VELSD DIR algorithms respectively.  
Fig 5.14 d Sagittal view of a typical patient anatomy with prostate, bladder and rectal 
volumes showing high dose islands at the edges of the organs at risk as studied in the 
deformable bladder phantom 
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It is known that the smoothing parameters used in DIR algorithms have a significant 
impact on dose warp accuracy[104]. MIM uses an intensity based algorithm which seeks 
to minimize the intensity differences between two images while the intensity based B-
spline algorithm used by VelocityAI tries to balance both the intensity information 
regularized by the inherent cost function and the spatial information regularized by the 
smoothness criteria[174]. The presence of uniform low contrast regions throughout the 
deformable bladder phantom makes this scenario particularly challenging for both the 
commercial algorithms studied because of the lack of intensity differences in the internal 
anatomy of the phantom. In the absence of user ability to edit the deformation parameters 
in the commercial DIR platforms, both the algorithms interpolated the deformation 
incorrectly in low contrast regions as the deformation was increased beyond 30N causing 
the resultant errors in dose warping. It is likely that the registration accuracy and 
consequently the dose warping accuracy would have been improved in the presence of 
high contrast features like implanted fiducial markers inside the phantom as found in the 
study using deformable gel[102] . A similar approach with implanted aluminum fiducial 
markers will be done in future studies using the deformable bladder phantom. 
The deformable phantom used in this study has a uniform CT number (±10 HU) and 
density similar to bladder, prostate, pancreas, stomach, kidney, liver, breast, diaphragm 
etc., in human anatomy[102, 171] and, as such, the results in this study would apply to 
those organs. The results do not apply to dose warp accuracy in density changing 
anatomy like the lung or where the mass is not conserved (full vs. empty bladder, organ 
atrophy, tumor inflammation etc). Although symmetric bilateral compression was 
studied, future study will include asymmetric compression, changes in the direction of 
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applied force, and 3D compression. The viscoelastic polymer used can be molded to any 
organ shape and has the potential to adjust the tensile properties to match other organs in 
human anatomy which will be subject of future work. 
5.15 Conclusion 
We have demonstrated the efficacy of dose warping using a tissue equivalent deformable 
bladder phantom for a range of mass and density preserving deformation states. The 
deformation observed was correlated with the applied force showing a linear response for 
both 1D and 3D deformation. A threshold limit of 13mm maximum deformation (1D) 
along direction of applied force and 6.8 mm 3D deformation was established beyond 
which deformable dose from DIR algorithms does not agree with true dose received by 
organ in terms of 3D γ3%, 3mm criteria for the commercial DIR algorithms studied.  This 
illustrates dose recalculation may be necessary for deformations larger than the threshold 
limit derived. For dose painting, although warped doses from DIR may agree with the 
TPS dose in the deformed geometry in terms of overall γ3D pass rates, the dose volumes 
from DIR may be significantly different from the true volume of dose received by the 
target. None of the DIR algorithms studied were able to accurately model the dose 
warping in reference image when compared to the true dose received by the organ in 
deformed geometry due to the uniform low contrast regions present throughout the 
bladder phantom.  
In the absence of user ability to edit the deformation parameters in the commercial DIR 
platforms, one should carefully evaluate the dose warp accuracy in a clinical context 
before routine implementation. The accuracy of deformable image registration does not 
guarantee accuracy of deformable dose. 
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Chapter 6 Summary and applications for future work 
6.1 Summary and general conclusions: 
In this dissertation we have presented a framework to include organ deformation in 
adaptive dose delivery. First, the need for clinical adaptation of treatment plans was 
demonstrated using daily imaging data from 10 patients treated for localized prostate 
cancer[16]. 
It is clear DIR is needed to translate anatomical information between two imaging study 
sets that exhibit organ deformation. Although there are various DIR algorithms available, 
there is no universal consensus on how to validate their accuracy in the context of 
radiotherapy clinical applications. 
DIR validation using deformable physical phantoms is an extremely challenging task 
given the fact no physical phantom can be sophisticated enough to reproduce the various 
organ deformations occurring in human body. Our work is the first published data that 
presented a novel way to evaluate DIR performance by synthetically deforming  patient 
CT data to mimic clinically observed organ deformation and using the DVF from that as 
the ground truth to evaluate the accuracy of DIR[18]. This approach has since gained 
acceptance in the radiation oncology community as other research groups have used a 
similar approach to validate the accuracy of DIR [174, 210]. The framework presented in 
our work based on anatomical correspondence, physical characteristics of deformation 
field and image characteristics can facilitate DIR verification with the ultimate goal of 
implementing adaptive radiotherapy. One of the major conclusions of  our study[18] was 
the fact that although there are several methods to evaluate the accuracy of DIR (Inverse 
consistency error, Mean square error, accuracy of RT structures, etc..) the clinical 
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applicability of a particular chosen metric to evaluate the accuracy of DIR depends on the 
deformation observed. 
This dissertation also establishes the fundamental relationship between organ 
deformations with the physical force producing it as in the case of a second generation 
medical simulator (Fig 1.7 in chapter 1). This work was the first study from a radiation 
therapy investigation that evaluated the organ deformation and subsequent dose warping 
accuracy from the “dose deformation “workflows in commercial DIR platforms from the 
context of applied force. A quantitative relationship between force and deformation has 
the potential to create simulated deformations of various organs if their biomechanical 
properties are known and can be potentially used by clinicians to adapt margins in a dose 
painting scenario. A deformable bladder phantom with mechanical and tensile properties 
comparable to human bladder was designed which was used to assess dose warp accuracy 
from various commercial DIR algorithms studied. Our study also highlights the 
importance of validating the volume of dose from various DIR algorithms as traditionally 
used 3D gamma pass rates may not accurately describe dose warping for dose painting 
scenarios. An entire range of organ deformation from 3mm (10N) to 34mm (70N) was 
studied representing symmetric bilateral compression of equal displacement. Our future 
study will include asymmetric compression, changes in the direction of applied force, and 
3D compression. The viscoelastic polymer used can be molded to any organ shape and 
has the potential to adjust the tensile properties to match other organs in human anatomy 
which will be subject of future work. 
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In the next section we highlight the potential applications of the methods and tools 
developed as part of this dissertation to other radiotherapy clinical applications which 
will also be subject of future work. 
6.2 Implanted fiducial markers in the deformable bladder phantom 
As discussed in section 5.14 in chapter 5, the principal reason for failure of DIR based 
dose warping was because of the presence of uniform low contrast regions in the 
deformable bladder phantom where the accuracy of DIR algorithm and the generated 
DVF is prone to errors because of the lack of information or features that drive the re-
distribution of voxels. Consequently any DIR algorithm will work more optimally if there 
are contrast rich features between the source and target images. To improve the 
applicability of dose warping and test the results for the same applied deformation as 
before, we implanted 21 aluminum markers distributed at random locations across the 
phantom as shown in figure 6.1 below. 18 markers were 1.5mm in size while 3 markers 
were 2.5 mm in size.  The implanted markers will also be used to test the accuracy of 
image registration by comparing the position of fiducial markers from direct 
measurement in target image (undeformed) to those obtained from the calculated image 
obtained by applying the corresponding DVF to each deformed image from 20N to 70N. 
An example image at 20N deformation is shown in figure 6.2 below.  
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Figure 6.1:  21 implanted aluminum markers in deformable bladder phantom to improve 
the accuracy of DIR in low contrast regions 
 
Figure 6.2:  Position of fiducial markers before and after applying the DVF at 20N 
deformation 
Before DIR Calculated target 
image by 
applying DVF 
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6.3 Extension of current project to other radiotherapy clinical applications 
In this section the application of tools and methods developed as part of this dissertation 
to other potential clinical applications will be highlighted.  
Lung 
It is well known that the chest wall is an important dose limiting structure when treating 
lung tumor or breast tumor. Understanding the characteristics of chest wall motion is 
poorly known. As reported in Hui et al[211]., inadequate margin around chest wall may 
under dose to the chest wall. Further, overdosing the ribs can cause chest wall toxicity. 
Studies have shown that 30 Gy to the chest wall can cause severe fractures to the ribs 
along with pain.  
Several studies have shown rib fractures have been observed with doses as low as 20-26 
Gy.[212-214] . For example Stephans et al[213] retrospectively contoured  the chest wall 
for 45 SBRT patients who were treated using treatment plans without specific chest wall 
avoidance criteria. After a median follow up of 18.8 months, 10 patients were shown to 
have chest wall toxicity which was correlated to tumor size and the chest wall dosimetry. 
We  studied the motion of the ribs in order to determine the margin that should be placed 
on the chest wall due to motion, to quantify the dose error at each position[29]. Our 
procedure includes importing the MIP (Maximum Intensity Projection), AVGERAGE, 
and non-gated CT scan and contouring a GTV on each image set. The GTV volumes are 
combined to make the treatment target volume. (ITV,internal target volume). We 
determined 3 points in the CW by using an x,y,z coordinate on the planning system for 7 
patients and observed the motion for each point in the 10 phases. We examined the 
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diaphragm displacement in each phase (0%-90%, 10% increments) and also at the 
corresponding displacement of the chest wall. (See figure 6.3 and 6.4).  The motion 
during each phase was quantified and averaged for 7 patients. The chest wall motion was 
compared to the diaphragm motion and the tumor motion in order to determine the 
relationship of the motion and the corresponding dose error to the chest wall due to 
motion 
 
Figure 6.3 illustrating the motion of diaphragm 
 
 
 
 
 
 
Figure 6.4 illustrating the motion of chest wall in 2 different breathing phases. 
 
20% Phase 80% Phase 
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6.2.1 Results: 
Figure 6.5 shows the displacement of the chest wall for ribs 3, 5, and 7 at each phase of 
the breathing cycle and the corresponding diaphragm motion for an average of 7 patients. 
Rib 3 moved between 1-3mm with a standard deviation of 0.1mm. 
Diaphragm movement was between 4-9mm, with a standard deviation of 1.4mm. Further 
the 50% phase showed the largest change in lung volume (cc) when averaged over the 
patients we evaluated as shown in figure 6.6.  
6.2.2 Conclusions 
Quantification of diaphragm motion alone may not be enough to determine chest wall 
margin since the chest wall motion is asymmetric with respect to the diaphragm motion. 
Due to the asymmetric chest wall motion with respect to the tumor, 4DCT scans should 
be considered for breast, lung and TMI to evaluate the tumor and chest wall motion. 
6.2.3 Extension of the lung study in the context of this dissertation 
Instead of following 3 points on the chest wall manually which is extremely time 
consuming and still not comprehensive, the entire ribs from T 1 to T 12 were contoured 
and the motion of each rib can be computed using the center of mass displacement.  
We deformably registered each of the10 breathing phases of 4D CT with planning CT 
using the custom developed open source DIR modules. The deformation matrix from the 
image registration is applied to RT Dose from the original plan. Deformed Doses can 
then be derived for each breathing phase of 4D CT. This is shown below in figs 6.7 and 
6.8 for the 20% and 80% phase respectively. The deformed doses can then be summed 
through all the 10 phases of breathing cycle to obtain a “4D Dose” and the DVH from 4D 
dose can then compared to original RT Dose. This approach has been used in abdomen 
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and liver sites.[79, 81]The resultant DVH for each rib from 4D dose is shown in figure 
6.9.  We are currently analyzing this data and the results will be published soon. 
 
 
 
Figure 6.5 showing the motion of diaphragm in comparison to motion of chest wall as 
quantified by ribs 3, 5, 7 
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Figure 6.6 Lung volume changes (cc) as function of breathing phase 
 
 
Figure 6.7 illustring the undeformed dose and deformed dose in the 20% breathing phase 
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Figure 6.8 illustring the undeformed dose and deformed dose in the 80% breathing phase 
 
 
 
Figure 6.9 illustraing the DVH from 4D dose for all the vertebral bodies (T1 through 
T12) 
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6.2.4 Total Marrow Irradiation (TMI) 
The feasibility of using helical tomotherapy for TMI was demonstrated by Hui et al[211]. 
A TMI work flow methodology can be implemented based on the DIR tools developed as 
part of this dissertation similar to the work of Chao et al[215] as shown in figure 6.10. 
MVCTs are routinely acquired prior to each TMI treatment. Regions of interest can then 
be contoured on each MVCT. The dose for each fraction can be calculated based on the 
MVCT using the Tomotherapy workstation. DIR can be used to establish voxel-to-voxel 
correspondence between the MVCT and the treatment planning kVCT.  
The resultant deformation vector field can be used to map the reconstructed dose from 
each fraction to the same point on the plan dose, and a voxel-to-voxel summed dose from 
all fractions delivered can be potentially computed   
The reconstructed dose distribution and its dosimetric parameters can be compared with 
those of the original treatment plan to evaluate the delivery efficacy or modify the plan 
during the course of therapy if significant deviations are found. 
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Figure 6.10 Adaptive work flow using DIR in TMI treatment based on Chao etal[215] 
6.3 On-line Adaptive Radiation Therapy 
On-line ART is a paradigm which attempts to adapt the delivered dose based on daily 
soft tissue imaging feedback while the patient is still on table. On-line ART is different 
from IGRT  beacause IGRT only corrects for positional variation of target and does not 
take onto account organ deformation for both target and critical structures. The goal of 
on-line ART is to dynamically adapt treatment delivery accounting for organ 
deformation. There are two different methods of implementing on-line ART based on 
daily volumetric CT imaging.  Some research groups have used MLC based tracking[216, 
217] whereby MLC aperture shape and leaf sequencing is varied  to adapt delivery based 
on daily target volume while others have performed a more robust fluence/aperture 
optimization based on daily imaging as done for treatment planning CT. The key 
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requirement for on-line ART in both methodologies is to keep the overall treatment time 
comprable to conventional IGRT treatment. In that regard, optimization and dose 
calculation schemes using graphics processing unit(GPU)  have shown great promise in 
implementing on-line ART.[218-220]. GPU computing have access to hundreds of 
processing cores that can be used for parallel computing thereby providing a very 
powerful computing platform at a fraction of processing times for various scientific 
applications in medical physics[221]. For example automatic segmentation of tumor and 
organs at risk in a 4DCT scan using a Demons algorithm can be achieved in 7 seconds 
using GPU processors [222]. Similarly a fluence map treatment plan re-optimization for a 
prostate IMRT plan was done in 2.8 seconds[220] and a direct aperture optimization for 
prostate and head and neck IMRT plans was done between 0.7 and 3.8 seconds[219] 
using NVIDIA Tesla C1060 GPU card.  It has also been shown that a robust dose 
calculation using convolution/superposition algorithm can be performed in under 2 
seconds using GPU computing.[223]. Thus if  image segmentation, re-optimization and 
dose calculation can be performed in under 2 minutes using GPU computing then on-line 
ART can be clinically implemented. A work flow model for clinical implementation of 
on-line ART is given in fig 6.11. and is subject of future research work. 
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Figure 6.11 An example model for clinical implementation of on-line ART 
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APPENDIX-Documentation of custom modules developed in this project and 
implemented in 3DSlicer 
Slicer modules for dosimetric verfication 
A. Preliminaries 
We used 3D Slicer (www.slicer.org) as our visualization platform. Several organizations 
are involved in the development of Slicer. Slicer is open source and supports loadable 
modules, both of which favor us in this regard. 
A.1 Installing Slicer 
We use a custom, modified version of Slicer, to support RT Dose files.( although since 
developing these modules, Slicer RT was developed in open source format and can import 
RT dose files)  Uninstall any existing versions of slicer you may have on your computer. 
Then get this custom version from author, Raj Varadhan. Please send email to 
rvaradhan@mropa.com for more details. Please use windows 7, 64-bit O/S with minimum 
of 8GB RAM. 
Install, following the usual options. If you are using Windows Vista, it may be preferable 
to not install it in “Program Files”, since log files are written out by modules in the 
installed folder, where write access may be denied to non-administrative users. 
A.2 Installing Custom Modules 
We package functionality in the form of Slicer modules. These may be invoked both from 
within Slicer, or from the command line. Typically command line invocation is verbose, 
giving you lots of log messages as you go along, while the GUI invocation is silent. 
Functionally, they remain the same. 
Get the modules from author Raj Varadhan 
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Unzip. Place the command line (.exe) and plugin (.dll) files in 
<YourSlicerInstallPath>/lib/Slicer3/Plugins/   . This is typically 
c:\Program Files\Slicer3\ 3.5.2009-12-05\lib\Slicer3\Plugins 
B. Loading data 
Extensive documentation on Slicer can be found at www.slicer.org. A minimal description 
on getting started with loading the KVCT is below. 
B.1 Loading the KVCT data 
While Slicer can load DICOM data, our DICOM library is still somewhat primitive. It 
requires that each series is isolated to a single folder. Lets create a folder kvctdata/ . 
Please all the CT data that correspond to this series in the folder. Be sure to leave out any 
scout files or the Dose and RT Plan files out 
Our example data folder contains 102 files ... 
HeadNeckCase/kvctdata/CT.1.3.12.2.1107.5.1.4.51607.300000090921134542609000003
46.dcm 
... 
HeadNeckCase/kvctdata/CT.1.3.12.2.1107.5.1.4.51607.300000090921134542609000004
47.dcm 
 
Select File ->Add Volume and navigate to HeadNeckCase/kvctdata/ . Select “Parse 
Directory”. Select the series “Rad therapy planning” that shows up with 102 files. Enter a 
meaningful name to remember it by. Let's type in “kvct” on the “Name” field and hit 
apply. 
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B.2 Basic functionality 
Window / level functionality may be accessed from the “Volumes” module. Volume 
Rendering may be accessed from the “Volume Rendering” module. Fiducials from the 
“Fiducials” module. Measurements / rulers etc from the “Measurements” module. 
 
Each image tab allows one to specify the Orientation (Axial/cornal/sagittal), the label 
image of any, the foreground image if any and the background image. This allows one to 
overlay label maps (in this case the PTV) or overlay a registered image. One can toggle / 
fade between the background and foreground 
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C. Converting RT contours to binarized label map images 
Let's convert the DICOM RT contours to a label map image. Let's create a directory to 
hold these label map files : 
HeadNeckCase/StructureSetImages/ 
 
Select Modules from the toolbar above. Navigate to the group “Raj” and select the 
module→ “RTStruct to label map” On the module tab, Select the following parameters: 
 Template Volume : kvct 
 OutputDirectory ...../HeadNeckCase/StructureSetImages/ 
 InputFile is the RT structure set file : RS.......dcm 
Hit Apply. The module should take about 20 minutes to run. You should find 40 
Structure_<NAME>.mha images in your OutputDirectory. 
The same module can be invoked from the command line as well and this reports 
progress.... 
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D. Loading / Overlaying the RTContour label maps. 
Select File → Add Volume. Navigate to the OutputDirectory. Let's load one of the 
structures, the PTV : (Structure_PTV_6300.mha). Check “Label Map” ON. Perhaps, key 
in a meaningful name. Hit Apply. 
You should see the label map overlaid on the KVCT data as shown above 
E. Registration 
E.1 Loading the CBCT data 
Let's now load the CBCT image as well in Slicer. Follow the same process as the KVCT. 
ie. Isolate the CBCT files in a directory. Select File → AddVolume. Navigate to the 
folder. Hit “Parse Directory”. Select the appropriate series , in this case, “Unknown 
Series (58 files)”. 
E.2 Dilation of the PTV mask 
We will attempt to restrict our registration to the PTV and its vicinity. This may not be 
necessary always. Let's Select the module “Raj → ImageManipulation → 
BinaryDilateFilter”. 
- Select the label overlay : “Structure_PTV_6300” as the Input Volume. 
- On Output Volume, select “Create New Volume”. You may wish to name it as 
“Structure_PTV_6300_dilated”. 
- Select a “Kernel Radius of “6”. 
- Hit Apply 
The resulting displayed volume is the resampled volume. 
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E.3 Registration of the CBCT to the KVCT 
We first look at the match between the unregistered CBCT and the KVCT. To do this, 
select KVCT as the “background image”, and the CBCT as the foreground image. This 
aligns the images using their origin (derived from the DICOM image position patient 
tag). Toggle/fade the background and foreground. As can be seen, the two images are 
quite misaligned
 
 
Unregistered images (KVCT background and CBCT foreground) 
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E.3.1 Rigid registration 
We will first do a rigid registration of the CBCT to the KVCT. Traverse to the Modules → 
Raj → Registration → RegisterImages. Use the following parameters : 
IO 
FixedImage: KVCT MovingImage: CBCT 
Resample Image: Create New Volume (Give a meaningful name, say CBCT-
RigidRegToKVCT) 
Registration Parameters Load Transform : None 
Save Transform: Create New Transform (Give a meaningful name, say CBCT-
RigidRegToKVCT-Tfm) Initialization: Image Centers 
Registration: Pipeline Rigid Metric: Mattes MI 
 
Advanced Registration Parameters: Verbosity level: Verbose 
Fixed Image Mask: None Interpolation: Linear 
 
Advanced Rigid Registration Parameters: Rigid Max Iterations : ~200 
Rigid Sampling Ratio : ~0.02 
(The larger these parameters are, the more time it takes and the more accurate registration 
typically is). Hit Apply.... 
 
After about 2-3 minutes, you should have a rigid registration. 
This initializes the image based on their centers and then performs a rigid registration. The 
resulting symmetric rigid registration transform matrix (composed of a rotation and a 
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translation) can be viewed on the “Transforms” tab. You may overlay the two images to 
see the results of the rigid registration. 
One can also use the “Checkerboard filter”, from Modules → Filtering → Checkerboard 
filter to view a NxMxR checkerboard of the two images. 
 
 
The resulting metric and transform values at each iteration of registration can be seen from 
the output log, retrieved by hitting the “X” button at the bottom right and looking at the 
results on the “Register Images Standard Output”. 
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E.3.2 Deformable registration using B-spline algorithm. 
Note: Since the development of these modules Slicer RT supports B-spline registration 
in their latest version Slicer 4.3 
Deformable registration is typically performed as the second pass once you are satisfied 
with the results of the rigid registration. We will use the same “Register Images” Module. 
We will also restrict the deformable registration to the dilated PTV region. Use the 
following parameters 
IO 
FixedImage: KVCT MovingImage: CBCT 
Resample Image: Create New Volume (Give a meaningful name if you like, say CBCT-
DeformableRegToKVCT) 
Registration Parameters 
Load Transform : CBCT-RigidRegToKVCT-Tfm 
Save Transform: Create New Transform (Give a meaningful name if you like, say CBCT-
DeformableRegToKVCT-Tfm) Initialization: None (We initialize based on the transform 
resulting from rigid registration) 
Registration: Pipeline BSpline Metric: Mattes MI 
Advanced Registration Parameters: Verbosity level: Verbose 
Fixed Image Mask: Structure_PTV_6300_dilated Interpolation: Linear 
Advanced Rigid Registration Parameters: 
Rigid Max Iterations : ~50 (we've already performed a global rigid registration. This does 
a rigid registration with samples drawn from the mask, which really is not necessary) 
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Rigid Sampling Ratio : ~0.02 Advanced Bspline Registration Parameters: Bspline Max 
Iterations : 40 
Bspline Num Levels: 1 Bspline Sampling Ratio : 0.02 Control point spacing: 60 
The deformable registration will typically take 15~ 30 min, depending on the parameters 
on the Bspline tab. The smaller the control point spacing, the larger the sampling ratio 
and the larger the number of iterations, the more the time taken. 
The log of the B-spline registration along with the computed transform is written out to a 
file bspline-registrationlog.txt. This contains the transform and the current metric value 
and could be used as some indicator of progress. 
One should be able to view the registered results in the same manner as above. 
Future work: 
We should confine the B-spline grid to the mask. At the moment the grid is defined and 
computed over the entire image, although the samples used for computation of the metric 
is restricted to the mask. This is wasteful. We expect to achieve a 4x speedup by 
restricting the B-spline grid in addition to the metric, to the masked region. 
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E.3.3 Running RegisterImages from the command line 
One can run RegisterImages from the command line. An example is shown for the 
uploaded lung cancer case : ( In addition you specify the directory path in the below 
command line on where the input and output files reside) 
RegisterImages --resampledImage AfterDeformationRegisteredToBeforeDeformation.mha 
--registration PipelineBSpline --initialization ImageCenters --verbosityLevel Verbose 
--metric MattesMI --minimizeMemory --interpolation Linear --rigidSamplingRatio 0.02 
--rigidMaxIterations 200 --affineSamplingRatio 0.02 --affineMaxIterations 100 
--controlPointSpacing 64 --bsplineSamplingRatio 0.05 --bsplineMaxIterations 40 
--bsplineNumberOfLevels 1 BeforeDeformation.mha AfterDeformation.mha 
 
The parameters --controlPointSpacing , --bsplineSamplingRatio , 
--bsplineMaxIterations have a direct impact on the run-time. The larger the 
controlPointSpacing, sampingRatio and the smaller the number of iterations, the faster the 
execution. 
At the end of the registration, you should have a DeformationField.mhd and a 
DeformationField.raw file in your directory. You may load these in Paraview to 
visualize the deformation. 
The figure below shows the overlay of the two images in VolView using the “Merge 
Volumes” plugin 
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F. Visualizing the deformation field in Paraview 
(a) Load the dataset using File->Open. Paraview cannot load DICOM data. One must 
convert it to a MetaImage or VTI. 
(b) Filters -> Glyph should show you the deformation field. By default a reasonable 
masking of the points is done so as to avoid cluttering the display. You may want to see 
the effect of disabling “Mask Random Points” and setting the “Maximum number of 
points” to manually control the number of displayed glyps 
(c) One can also load the Input data and overlay the field on the data. File → Open 
followed by Filters → Slice. One can change the color mapping of the displayed slice by 
clicking on the slice nodes' “Display” tab → “Edit Color Map” → “Choose Preset” → 
Grayscale. 
 
 
 
 
  208 
G. Warping the dose file using the registration results 
The plugin takes a 3D image and warps it using a deformation (vector) field image. The 
loaded image is expected to be the image to be warped (also known as the moving 
image). The module has one parameter namely: the deformation field. The field is 
expected to have the same size, origin, spacing as the warped volume. 
If you supply the moving image as the input to the Warp plugin, and set the deformation 
field as that resulting from the registration (in Section E.3.3), you should get the same 
output as the registered volume. This plugin may be run from Slicer or invoked from the 
command line : 
WarpImageUsingDeformationField   --field  DeformationField.mhd 
AfterDeformation.mha AfterDeformationWarpedUsingDeformationField.mha 
The file  AfterDeformationWarpedUsingDeformationField.mha should be identical to  
AfterDeformationRegisteredToBeforeDeformation.mha 
Similarly one may warp the dose file
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H. Warped dose accumulation 
The plugin takes two dose images and simply adds them to produce a new result. This can 
be done with each successive warped dose image to get the cumulated dose. (One would 
read in the dose images are read via the ImportRTDose plugin and warp them with the 
plugin in Section G.). The plugin may also be invoked from the command line, for 
instance as : 
CumulateDose    DoseKvct.mha  WarpedDoseCBCT1.mha  DoseKvctAndCBCT1.mha 
CumulateDose    DoseKvctAndCBCT1.mha  WarpedDoseCBCT2.mha  
DoseKvctAndCBCT1AndCBCT2.mha 
 
I. Compare deformation field to reference field 
For dense deformation fields, this is equivalent to computing the MSE between the 
registered and the source image. The plugin MSE found in Raj → ImageManipulation 
computes this. The plugin expects as input the fixed image and the moving image. Slicer 
does not yet support reporting of results on the UI. Hence the output is written to a file. 
The output directory where the MSE between the source and target are stored is expected 
as input on the UI. The file MSEInfo.txt should contain the Sum of Squared Differences, 
the MSE and Root MSE. 
 
The displayed image should show the absolute difference between the two images ( | 
Image1 – Image2| ). As usual the plugin may be invoked from the command line : 
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MSE --outputdirectory c:/tmp c:/Data/BeforeDeformation.mha   
c:/Data/AfterDeformationRegisteredToBeforeDeformation.mha 
c:/Data/Output/DifferenceImage.mha 
J. Converting ImSimQA field to a metaimage 
The ImSimQA field cannot be loaded directly into paraview. To make it readable by 
paraview, use the “ReadImSimQAFieldWriteMetaImageField” plugin. This takes as 
input the ImSimQA dfm file and writes as output the field as a metaimage. 
The plugin may also be invoked from the command line as follows : 
ReadImSimQAFieldWriteMetaImageField  --inputfile  
c:/Data/TPSDeformationField_20100316.762690.dfm  --outputfile  c:/tmp/field.mha 
K. Importing an RT Dose file 
To import an RTDose file into Slicer, use the ImportRTDose plugin.  
The dose values are read from the DICOM file and multiplied by the DoseGridScaling 
(0x3004|000E) attribute. The resulting image will have dose values with units specified 
in DoseUnits attributes via DICOM tag (3004|0002). This is typically Gy. The plugin may 
also be invoked from the command line as follows : 
ImportRTDose  –InputFileName  
RD.1.2.246.352.71.7.1455740796.52337.20090923160357.dcm  Dose.mha 
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One can also contour the converted dose file in Paraview (see option to generate a series 
of values the range) and overlay it on the registered CBCT image along with the 
deformation field as shown below. 
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L. Compute the determinant of the jacobian 
- The jacobian of the transform or of a vector field is an MxN matrix, where M is the 
dimensionality of the transform and N is the dimensionality of the image. In our case, its 
a 3x3 matrix. 
- The sign of the determinant should tell you if the field is well behaved. If the negative, 
it indicates singularities in the field. Typically, if you looked at the deformation grid , one 
could see the misbehavior, usually the grid looping back on itself (thick of a figure 8). 
- The jacobian matrix itself tells you the local scale change or shearing or rotation 
involved in the deformation, if you factorized the matrix. 
- A determinant greater than 1 means its diverging. A determinant less than 1 means 
convergence. We have a Tumor change tracker module that essentially measures 
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volumetric change between scans at two time points by adding the jacobian determinants 
(of the deformation field) on all voxels in the tumor segmented mask region. 
- The min and max of determinant is an indicator of how smooth the spatial 
transformation is. The harmonic energy captures this metric well. It the Frobenius norm 
of the jacobian, and hence is inversely related to how smooth the deformation field is. 
The plugin expects the deformation field as the input and generates a floating point image 
representing the determinant of the jacobian. You may also run it from the command line 
as follows : 
ComputeDeterminantOfJacobian   DeformationField.mhd   
Jacobian_DeformationField.mha 
The figure below shows a slice of the jacobian field and the corresponding in-plane 
components of the deformation field in paraview. Note that the deformation field is well 
behaved; has a scalar range of [0.95, 1.04]. You will notice the larger vectors (red) 
diverging out of the bright regions in the image (regions with |J(T(x)|>1) and converging 
into darker regions (regions with |J(T(x)|<1) as shown below.
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M. Compute the harmonic energy in the field 
The min and max of determinant of the jacobian is an indicator of how smooth the spatial 
transformation is. The harmonic energy captures this metric well. It the Frobenius norm 
of the jacobian, and hence is inversely related to how smooth the deformation field is. 
The neighborhood size used in computing the harmonic energy is 1. 
The plugin expects the deformation field as the input and generates a text file containg the 
result. You may also run it from the command line as follows : 
ComputeHarmonicEnergy  DeformationField.mhd  
HarmonicEnergy_DeformationField.txt Harmonic energy of deformation field : 
DeformationField.mhd is 8.30813e-05 
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APPENDIX 
Troubleshooting: 
(a) I am trying to run the plugin from the command line, but I get “Error while loading 
shared libraries: ....dll” 
You need to add the SlicerInstallationDirectory\bin to your path, so as to enable your 
application to find additional ITK / Slicer libraries.  
For instance: 
PATH=%PATH%;c:\Program  Files\Slicer3  a3.5.2009-12-05\bin 
 
